<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Medicine-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 84268,
    "choices": [
      {
        "id": 335652,
        "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
      },
      {
        "id": 335653,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 and Folic acid deficiency</span></p>"
      },
      {
        "id": 335654,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta thalassemia</span></p>"
      },
      {
        "id": 335655,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      }
    ],
    "text": "<p>Which type of anemia is associated with an elevated Mean Corpuscular Volume (MCV) and a normal Mean Corpuscular Hemoglobin Concentration (MCHC)? (NEET PG 2016)</p>",
    "unique_key": "Q6523231",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965089,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. B) Vitamin B12 and Folic acid deficiency</strong></p><p>&nbsp;</p><p>Vitamin B12 and folate deficiencies are classic causes of macrocytic anemia with elevated MCV (typically &gt;100 fL) and normal MCHC. These deficiencies impair DNA synthesis while RNA and protein synthesis continue, resulting in nuclear-cytoplasmic asynchrony and the production of larger red blood cells. The peripheral blood smear shows macrocytes that are often oval-shaped (macro-ovalocytes).</p><p>&nbsp;</p><p><strong>Evidences:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p><p>&nbsp;</p><ul><li>Macrocytic anemias show MCV values &gt;100 fL</li><li>Polychromasia describes red cells that are slightly larger than normal with a grayish-blue color on Wright-Giemsa stain</li><li>B12 deficiency affects myelination of the central nervous system while folate deficiency primarily affects rapidly dividing cells</li></ul><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Option A. Sideroblastic anemia</strong>: Characterized by ringed sideroblasts in the bone marrow and typically presents with microcytosis or normocytosis, not macrocytosis.</li><li><strong>Option C. Beta thalassemia</strong>: Associated with microcytosis (low MCV), hypochromia, and target cells. The MCHC is typically decreased.</li><li><strong>Option D. Iron deficiency anemia</strong>: Presents with microcytosis (MCV &lt;80 fL) and hypochromia (low MCHC). The peripheral blood smear shows small, pale red cells with increased central pallor.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Vitamin B12 and folate deficiencies impair DNA synthesis leading to megaloblastic changes with macrocytosis (elevated MCV) but normal MCHC, distinguishing them from other nutritional anemias.</p>",
    "correct_choice_id": 335653,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73055,
    "choices": [
      {
        "id": 291185,
        "text": "<p><span style=\"font-size:16px;\">Metabolic acidosis</span></p>"
      },
      {
        "id": 291186,
        "text": "<p><span style=\"font-size:16px;\">Metabolic alkalosis</span></p>"
      },
      {
        "id": 291187,
        "text": "<p><span style=\"font-size:16px;\">Respiratory acidosis</span></p>"
      },
      {
        "id": 291188,
        "text": "<p><span style=\"font-size:16px;\">Respiratory alkalosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 25-year-old female presents to the emergency department with complaints of dizziness and weakness. She reports a history of binge eating followed by self-induced vomiting for weight control. Arterial blood gas analysis reveals the following: (FMGE JAN 2025)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">pH: 7.50</span></li><li><span style=\"font-size:16px;\">PaCO\u2082: 48 mmHg</span></li><li><span style=\"font-size:16px;\">HCO\u2083: 33 mmol/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">What is the most likely acid-base disturbance in this patient?</span></p>",
    "unique_key": "Q9500657",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965103,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Metabolic alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This patient has metabolic alkalosis due to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Elevated <strong>pH</strong> (&gt; 7.45), indicating alkalemia.</span></li><li><span style=\"font-size:16px;\">Elevated <strong>HCO\u2083</strong> (&gt; 26 mEq/L), indicating metabolic alkalosis.</span></li><li><span style=\"font-size:16px;\">Clinical history of vomiting, which leads to the loss of chloride (via gastric acid - Hcl), resulting in hypochloremic metabolic alkalosis.</span></li><li><span style=\"font-size:16px;\">Binge eating followed by self-induced vomiting suggests that the patient may suffer from <strong>bulimia nervosa</strong>, a psychiatric illness.</span></li><li><span style=\"font-size:16px;\">Compensatory increase in <strong>PaCO\u2082</strong> (normal: 35-45 mmHg), as per expected compensation using the <strong>Modified Winter's formula for Metabolic Alkalosis</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Expected PaCO\u2082 = <strong>0.7 \u00d7 HCO\u2083 + 20</strong> (or) <strong>0.9 \u00d7 HCO\u2083 + 16</strong></span></li><li><span style=\"font-size:16px;\">In this case, let us use the second one: <strong>0.9 \u00d7 33 + 16 = 45.7 mmHg (\u00b1 2)</strong></span><br><span style=\"font-size:16px;\"><strong>So the expected range would be 44-48 mm Hg.&nbsp;</strong></span></li><li><span style=\"font-size:16px;\">The patient\u2019s <strong>PaCO\u2082 of 48 mmHg falls within the expected range.&nbsp;</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Metabolic acidosis</strong>: Incorrect, as this would present with <strong>low pH</strong> (&lt;7.4) and <strong>low HCO\u2083 (&lt;24)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Respiratory acidosis</strong>: Incorrect, as the patient\u2019s pH is 7.5 (alkalotic) and in acidosis pH would generally be low (&lt; 7.4)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Respiratory alkalosis</strong>: Incorrect, as this would present with <strong>low PaCO\u2082</strong> (&lt; 40) and high pH (&gt;7.4)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Chronic vomiting&nbsp;</strong>results in loss of chloride (in the vomitus), resulting in hypochloremic metabolic alkalosis. Metabolic Alkalosis is usually characterized by <strong>elevated pH and HCO\u2083</strong>, with appropriate respiratory compensation (<strong>elevated PaCO\u2082 - due to hypoventilation</strong>).</span></p>",
    "correct_choice_id": 291186,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11864,
    "choices": [
      {
        "id": 47422,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antihistone antibodies</span></span></p>"
      },
      {
        "id": 47423,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-dsDNA antibodies</span></span></p>"
      },
      {
        "id": 47424,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticentromere antibodies</span></span></p>"
      },
      {
        "id": 47425,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antinuclear antibodies</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young patient presents to the clinic with erythematous lesions over the exposed areas of the skin like hands, arms, chest, etc. She also complains of arthralgia and breathlessness. Which among the following antibodies will be useful in diagnosing this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" style=\"height:257px; width:300px\" /></p>",
    "unique_key": "Q8595702",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965083,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Anti-dsDNA antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient exhibits symptoms including erythematous lesions on sun-exposed areas of the skin, arthralgia, and breathlessness, which are characteristic of Systemic Lupus Erythematosus (SLE). The rash described is typical of an SLE rash and not dermatomyositis, which presents with rashes over the knuckles known as Gottron&#39;s papules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For diagnosing SLE, anti-dsDNA antibodies are very useful due to their high specificity. Although their sensitivity is relatively low (30-50%), the specificity is very high (&gt;90-95%), making them reliable markers for confirming the diagnosis of SLE. Anti-dsDNA antibodies are also associated with disease activity in SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antihistone antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are primarily associated with drug-induced lupus erythematosus, not classic SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anticentromere antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are typically seen in limited forms of scleroderma, particularly CREST syndrome, and are not associated with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antinuclear antibodies (ANA):</span></strong><span style=\"font-size:12.0pt\"> While ANA is a good initial screening test for SLE due to its high sensitivity, it lacks specificity. ANA can be positive in a variety of autoimmune conditions, thus it is not as specific as anti-dsDNA antibodies for diagnosing SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-dsDNA antibodies are highly specific for diagnosing Systemic Lupus Erythematosus (SLE), despite their moderate sensitivity.</span></span></span></p>",
    "correct_choice_id": 47423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84327,
    "choices": [
      {
        "id": 335880,
        "text": "<p>It is associated with Levine's sign</p>"
      },
      {
        "id": 335881,
        "text": "<p>The pain has a crescendo-decrescendo pattern</p>"
      },
      {
        "id": 335882,
        "text": "<p>The discomfort frequently radiates to the trapezius muscles</p>"
      },
      {
        "id": 335883,
        "text": "<p>Episodes generally last between 2 and 5 minutes</p>"
      }
    ],
    "text": "<p>Which of the following statements about angina pectoris is NOT correct? (NEET PG 2015)</p>",
    "unique_key": "Q7965054",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965114,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: C. The discomfort frequently radiates to the trapezius muscles</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Angina pectoris is characterized by chest discomfort that may radiate to the jaw, shoulder, back, or arm, but radiation specifically to the trapezius muscles is not a typical pattern of angina. Angina is classically described as a pressure, squeezing, or heaviness in the chest that can radiate to other areas but not typically to the trapezius muscles. The diagnosis of angina is based on three key features: chest discomfort that is aggravated by exertion or emotional stress and relieved by rest or nitro-glycerine within minutes.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A.</strong> It is associated with Levine's sign - This is correct. Levine's sign refers to the patient clenching a fist over the sternum to describe the sensation of chest pain typical of angina.</p><p>&nbsp;</p><p><strong>Option B.</strong> The pain has a crescendo-decrescendo pattern - This is correct. Anginal pain typically builds gradually, reaches a peak, and then subsides, rather than having sudden onset and offset.</p><p>&nbsp;</p><p><strong>Option D.</strong> Episodes generally last between 2 and 5 minutes - This is correct. Angina episodes typically last less than 5 minutes, often resolving within 30 seconds to 5 minutes, especially when the patient stops exertion or takes nitroglycerin.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Angina pectoris typically presents as chest discomfort that may radiate to the jaw, shoulder, back, or arm (not trapezius muscles), is triggered by exertion or emotional stress, and is relieved by rest or nitroglycerin within minutes.</span></p>",
    "correct_choice_id": 335882,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 45087,
    "choices": [
      {
        "id": 179995,
        "text": "<p><span style=\"font-size:12.0pt;\">Must be distinguished from Pulsus Alternans</span></p>"
      },
      {
        "id": 179996,
        "text": "<p><span style=\"font-size:16px;\">Is a sign of digitalis toxicity</span></p>"
      },
      {
        "id": 179997,
        "text": "<p><span style=\"font-size:16px;\">Compensatory pause is absent</span></p>"
      },
      {
        "id": 179998,
        "text": "<p><span style=\"font-size:16px;\">Rhythm is irregular</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">All of the following statements about Pulsus Bigeminus are true, except?<strong>&nbsp;</strong>(NEET PG 2017)</span></p>",
    "unique_key": "Q8423175",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965090,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: C. Compensatory pause is absent</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Pulsus bigeminus is characterized by a normal beat followed by a premature ventricular contraction (PVC), creating a pattern where every other beat appears weaker. This creates an alternating strong-weak pulse pattern. Importantly, PVCs typically have a compensatory pause following them, as the ventricle is refractory to the next normal sinus impulse.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Must be distinguished from Pulsus Alternans:</strong>&nbsp; Pulsus bigeminus must be distinguished from pulsus alternans as they present differently. Pulsus alternans is associated with severe left ventricular dysfunction, while pulsus bigeminus is due to premature beats.</p><p>&nbsp;</p><p><strong>Option B. Is a sign of digitalis toxicity</strong>: Digitalis toxicity can produce various dysrhythmias including premature ventricular contractions in a bigeminal pattern. It's a classic manifestation of digoxin toxicity.</p><p>&nbsp;</p><p><strong>Option D. Rhythm is irregular:&nbsp;</strong>Pulsus bigeminus demonstrates an irregular rhythm with normal sinus beats interrupted by premature ventricular contractions.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Pulsus bigeminus is an irregular cardiac rhythm characterized by normal beats alternating with premature ventricular contractions, which are typically followed by compensatory pauses as the ventricle is refractory to the next sinus impulse.</p>",
    "correct_choice_id": 179997,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11737,
    "choices": [
      {
        "id": 46914,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></span></p>"
      },
      {
        "id": 46915,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></span></span></p>"
      },
      {
        "id": 46916,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prothrombin time</span></span></span></span></p>"
      },
      {
        "id": 46917,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the MELD (2016) score are all except? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q1192876",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965087,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for liver transplantation and assesses the severity of chronic liver disease. The MELD score includes three laboratory values:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;CBI mnemonic = Creatinine, Bilirubin, INR are the parameters is MELD score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Currently Sodium levels to the score and MELD-Na score used for prognostication. Hyponatremia associated with adverse outcomes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Bilirubin:</strong> Reflects the liver&#39;s ability to excrete bilirubin.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>INR (International Normalized Ratio) for prothrombin time:</strong> Indicates the liver&#39;s ability to synthesize clotting factors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Creatinine:</strong> Assesses renal function, which can be compromised in liver failure. Additionally, sodium was added to the MELD score to improve its prognostic accuracy, resulting in the MELD-Na score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin is not a component of the MELD score. The key components are bilirubin, creatinine, and INR, with sodium also included in the updated MELD-Na scoring system to better predict outcomes in patients with end-stage liver disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: Harrison 21/Cirrhosis/Chap 344</span></span></strong></span></span></p>",
    "correct_choice_id": 46915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16339,
    "choices": [
      {
        "id": 65316,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
      },
      {
        "id": 65317,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
      },
      {
        "id": 65318,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B2</span></p>"
      },
      {
        "id": 65319,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with complaints of tingling sensation in hands and feet, generalised weakness, easy fatigability, pallor, and ataxia. Deficiency of which vitamin causes these symptoms? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q3487790",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965098,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Vitamin B12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency can lead to <strong>both hematological and neurological manifestations.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hematologically, it causes megaloblastic anemia, which is why patients may experience weakness, easy fatigability, and pallor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neurologically, it causes peripheral neuropathy, leading to tingling sensations in the hands and feet. It also affects the spinal cord, causing subacute combined degeneration due to demyelination of the posterior columns and corticospinal tracts, resulting in sensory ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin B1:</strong> Deficiency causes beriberi, which can be wet (causing cardiac failure) or dry (causing peripheral neuropathy). In severe alcoholics &amp; malignancy patients, it can cause Wernicke's encephalopathy and Korsakoff psychosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B2:</strong> Deficiency leads to riboflavin deficiency, causing cheilitis, glossitis (magenta colored tongue), and mouth sores.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B3:</strong> Niacin Deficiency causes pellagra, characterized by the 4D\u2019s: diarrhea, dementia, dermatitis &amp; death, which appears as a rash in sun-exposed areas, known as Casal\u2019s necklace.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency can cause megaloblastic anemia and neurological issues such as peripheral neuropathy and subacute combined degeneration of the spinal cord.</span></p>",
    "correct_choice_id": 65317,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11301,
    "choices": [
      {
        "id": 45170,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medication overuse headache</span></span></p>"
      },
      {
        "id": 45171,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tension headache</span></span></p>"
      },
      {
        "id": 45172,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic migraine</span></span></p>"
      },
      {
        "id": 45173,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cluster headache</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 37-year-old woman presents with headaches for 6 months. She has been taking analgesics regularly. The headache recently increased in severity for 3 days but was reduced on stopping the analgesic. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
    "unique_key": "Q3606385",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965094,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Medication overuse headache</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medication overuse headache (MOH) occurs in individuals who frequently use headache medications. The patient in this case has been experiencing headaches for six months and has been regularly using analgesics. The key indicator of MOH is the worsening of headaches with continued use of medication and improvement upon stopping the medication. This aligns with the patient&#39;s experience of increased headache severity for three days, which reduced once the analgesics were stopped.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MOH develops as a result of the brain becoming sensitized to the medication, leading to a rebound effect. This is a well-recognized phenomenon where the headache itself is caused by the frequent use of headache relief medication, leading to a cycle of medication use and headache.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tension headache:</span></strong><span style=\"font-size:12.0pt\"> Tension headaches are typically relieved by analgesics, not worsened. These headaches are often characterized by a feeling of a tight band around the head and can be managed effectively with over-the-counter pain relief medications.&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Treatment</span></strong><span style=\"font-size:12.0pt\">: Nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol are used to relieve pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chronic Treatment</span></strong><span style=\"font-size:12.0pt\">: Tricyclic antidepressants, such as amitriptyline, are employed to manage chronic symptoms and reduce the recurrence of headaches.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic migraine:</span></strong><span style=\"font-size:12.0pt\"> Chronic migraines are managed with both acute treatments for individual attacks and preventive treatments to reduce the frequency and severity of the headaches. While chronic migraines can be debilitating, they generally improve with proper prophylaxis and do not worsen with the use of analgesics. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment options include propranolol, topiramate, valproate, and monoclonal antibodies against CGRP (calcitonin gene-related peptide), such as erenumab. These are used to reduce the frequency and severity of migraine attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cluster headache:</span></strong><span style=\"font-size:12.0pt\"> Cluster headaches are severe, unilateral headaches that are treated with high-flow oxygen and subcutaneous sumatriptan during acute attacks. Preventive treatments include medications like verapamil. Analgesics are not typically the first-line treatment for cluster headaches and their use does not generally lead to worsening of the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Treatment</span></strong><span style=\"font-size:12.0pt\">: High-flow 100% oxygen inhalation or subcutaneous sumatriptan injections are recommended to alleviate the intense pain of acute cluster headache attacks.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chronic Treatment</span></strong><span style=\"font-size:12.0pt\">: Verapamil is used for long-term management to prevent the frequency and intensity of cluster headache episodes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medication overuse headache is characterized by the worsening of headaches due to frequent use of headache medications, and improvement upon cessation of the medication. This phenomenon highlights the importance of managing headache disorders with appropriate treatments and avoiding overuse of analgesics.</span></span></span></p>",
    "correct_choice_id": 45170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11872,
    "choices": [
      {
        "id": 47454,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Putamen</span></span></p>"
      },
      {
        "id": 47455,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subthalamic nucleus</span></span></p>"
      },
      {
        "id": 47456,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caudate nucleus</span></span></p>"
      },
      {
        "id": 47457,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globus pallidus</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presented with violent, flinging movements. Where is the lesion causing the hemiballismus seen? (INICET NOV 2022)</span></span></span></p>",
    "unique_key": "Q3909935",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965109,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subthalamic nucleus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus is characterized by involuntary, violent, flinging movements, typically on one side of the body. This condition is most commonly associated with a lesion in the subthalamic nucleus. The subthalamic nucleus plays a crucial role in regulating movements, and damage to this area can lead to the excessive, uncontrolled movements seen in hemiballismus. This differentiates it from lesions in other parts of the basal ganglia, which are associated with different movement disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Putamen:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the putamen are more commonly associated with chorea, which involves rapid, involuntary, and irregular movements, rather than the violent flinging movements of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caudate nucleus:</span></strong><span style=\"font-size:12.0pt\"> Similar to the putamen, lesions in the caudate nucleus typically result in chorea. The caudate nucleus is part of the striatum, and its dysfunction does not usually present with the violent movements characteristic of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Globus pallidus:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the globus pallidus often result in athetosis, which involves slow, writhing movements. This is different from the abrupt and forceful movements seen in hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus, characterized by violent, flinging movements, is most commonly caused by a lesion in the subthalamic nucleus.</span></span></span></p>",
    "correct_choice_id": 47455,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16340,
    "choices": [
      {
        "id": 65320,
        "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
      },
      {
        "id": 65321,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal atrial tachycardia</span></p>"
      },
      {
        "id": 65322,
        "text": "<p><span style=\"font-size:12.0pt;\">Ventricular fibrillation</span></p>"
      },
      {
        "id": 65323,
        "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Absent P waves is a feature of which of the following? (FMGE JUNE 2022)</span></p>",
    "unique_key": "Q7277086",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965124,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Atrial fibrillation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In atrial fibrillation, the atria do not contract effectively, leading to the absence of P waves on the ECG. The rhythm is irregularly irregular, and there is NO A wave in the JVP, NO p wave in ECG, NO fourth heart sound, and NO pre-systolic accentuation in mitral stenosis <strong>(4 NO\u2019s).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ventricular tachycardia:</strong> Characterized by wide QRS complexes and not the absence of P waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Focal atrial tachycardia:</strong> Will still show P waves, but they may be abnormal in appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ventricular fibrillation:</strong> Presents with a chaotic, irregular waveform without identifiable QRS complexes, P waves, or T waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The absence of P waves and an irregularly irregular rhythm on an ECG are characteristic of atrial fibrillation.</span></p>",
    "correct_choice_id": 65323,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11738,
    "choices": [
      {
        "id": 46918,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></span></span></p>"
      },
      {
        "id": 46919,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylthiouracil</span></span></span></span></p>"
      },
      {
        "id": 46920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine</span></span></span></span></p>"
      },
      {
        "id": 46921,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrouracil</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with Grave&#39;s disease was taking antithyroid medication throughout her pregnancy. The baby was born with aplasia cutis congenita. Which drug could have caused this condition? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q2125201",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965113,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a medication used to treat hyperthyroidism and is known to cause teratogenic effects if used during pregnancy. It can lead to a rare congenital condition called aplasia cutis congenita, where the baby is born with localized areas of missing skin. The use of carbimazole, especially during the first trimester of pregnancy, is linked with this embryopathy, which highlights the importance of careful medication selection in pregnant women with thyroid disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Methylthiouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although it is an antithyroid drug, it is less commonly used and not specifically associated with aplasia cutis congenita.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levothyroxine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a thyroid hormone replacement and is used to treat hypothyroidism, not associated with congenital defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option appears to be a distractor as no such common drug name exists that is relevant in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMZ, Carbimazole associated with embryonopathy in first trimester</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graves in Pregnancy:</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;16 weeks: PTU (MM teratogenic)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;16 weeks: MMI (PTU hepatotoxicity)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation: MMI (RAIA avoided 4-6 weeks after cessation of breastfeeding as RAI is concentrated in breast tissue)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Hyperthyroidism/Graves/Chap 384</span></span></strong></span></span></p>",
    "correct_choice_id": 46918,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11264,
    "choices": [
      {
        "id": 45022,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism due to disease in the pituitary</span></p>"
      },
      {
        "id": 45023,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism due to disease in the pituitary</span></p>"
      },
      {
        "id": 45024,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism due to disease in the hypothalamus</span></p>"
      },
      {
        "id": 45025,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism due to disease in the hypothalamus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient came to the hospital with complaints of lethargy, increased sleep, and weight gain. Investigations revealed low plasma TSH concentration. However, on the administration of TRH, the TSH levels increased. Which of the following conditions is likely in this patient?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
    "unique_key": "Q5604677",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965093,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hypothyroidism due to disease in the hypothalamus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical history is suggestive of hypothyroidism. Presence of low TSH with suspected hypothyroidism indicates loss of Log relationship of TSH &amp; fT4 indicating a central cause. Administration of TRH improving TSH level indicates TRH deficiency which is mainly produced from the hypothalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong> <strong>Hyperthyroidism due to pituitary</strong>: &nbsp;Cause like TSHoma is very rare. Also, symptoms of thyrotoxicosis are not present in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. In pituitary disease: </strong>TSH will not improve with TRH administration as the gland is defective and cannot produce TSH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. </strong>Thyrotoxicosis symptoms are not present in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a patient with hypothyroid symptoms and low TSH that responds to TRH administration, consider hypothalamic dysfunction as a probable cause. This is indicative of secondary hypothyroidism due to a lack of TRH production, affecting the pituitary\u2019s secretion of TSH in the absence of exogenous stimulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hypothyroidism/Chap 383</strong></span></p>",
    "correct_choice_id": 45024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47604,
    "choices": [
      {
        "id": 190027,
        "text": "<p><span style=\"font-size:12.0pt;\">Absent a wave</span></p>"
      },
      {
        "id": 190028,
        "text": "<p><span style=\"font-size:12.0pt;\">Absent y descent</span></p>"
      },
      {
        "id": 190029,
        "text": "<p><span style=\"font-size:12.0pt;\">Prominent y descent</span></p>"
      },
      {
        "id": 190030,
        "text": "<p><span style=\"font-size:12.0pt;\">Absent x descent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has muffled heart sounds with low BP and elevated JVP. What is the likely JVP finding?&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q7698699",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965127,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Absent y descent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of muffled heart sounds, low blood pressure, and elevated jugular venous pressure (JVP) suggests cardiac tamponade. In cardiac tamponade, the JVP is elevated, and the typical waveform finding is a prominent x descent with a blunted or diminished y descent. This pattern is due to the restricted filling of the right atrium and ventricle during diastole because of the pressure exerted by the pericardial fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Absent a wave:&nbsp;</strong>This is seen in patients with atrial fibrillation, where there is no organized atrial contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Prominent y descent:&nbsp;</strong>This is seen in patients with constrictive pericarditis, where there is a rapid early diastolic filling, known as Friedrich's sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Absent x descent:&nbsp;</strong>This is a feature of tricuspid regurgitation, where the backward flow of blood during systole reduces the x descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, the JVP waveform shows a prominent x descent with an absent or blunted y descent. This is due to the restricted filling of the right heart chambers caused by the pericardial fluid, leading to characteristic clinical signs such as muffled heart sounds, hypotension, and elevated JVP</span></p>",
    "correct_choice_id": 190028,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11245,
    "choices": [
      {
        "id": 44946,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory condition</span></span></p>"
      },
      {
        "id": 44947,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Descending paralysis is seen</span></span></p>"
      },
      {
        "id": 44948,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmapheresis is a treatment method</span></span></p>"
      },
      {
        "id": 44949,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Demyelinating disorder</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about Typical Guillain-Barre syndrome except: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q8290426",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965118,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Descending paralysis is seen</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain-Barre Syndrome (GBS) is typically characterized by ascending paralysis, starting from the lower extremities and moving upward, not descending paralysis. This pattern begins with weakness in the legs that spreads to the upper limbs and the face, associated with the demyelination of peripheral nerves. The condition is indeed inflammatory and primarily affects the peripheral nervous system, leading to demyelination and sometimes axonal damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inflammatory condition:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS is an acute inflammatory demyelinating polyneuropathy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasmapheresis is a treatment method:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, plasmapheresis is used to remove antibodies from the blood that are thought to be involved in the immune attack on the peripheral nerves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Demyelinating disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS involves the demyelination of peripheral nerves, leading to muscle weakness and paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GBS produces neuro-radiculopathy due to demyelination causing ascending paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of Descending paralysis (<strong>Mnemonic: Bipolar disorder [BPD]</strong>):</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B: B</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">otulism</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P: P</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orphyria, Polio</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D: D</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">iphtheria</span></span></span></span></p>",
    "correct_choice_id": 44947,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55346,
    "choices": [
      {
        "id": 220845,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior MI</span></span></p>"
      },
      {
        "id": 220846,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inferior MI</span></span></p>"
      },
      {
        "id": 220847,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lateral MI</span></span></p>"
      },
      {
        "id": 220848,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Posterior MI</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 40-year-old patient presents with chest pain and an ECG was taken. What will be the likely diagnosis? (FMGE JULY 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-101033.png\" style=\"height:114px; width:300px\" /></span></span></p>",
    "unique_key": "Q2632483",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965102,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Anterior MI</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The ECG shows ST elevations primarily in leads V1, V2, V3, and V4. These elevations are also seen to some extent in V5 and aVL, with reciprocal ST depressions in leads II, III, and aVF. These findings are characteristic of an anterior myocardial infarction (MI).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Inferior MI:</strong> This would present with <strong>ST elevations in leads II, III, and aVF</strong>. These changes are not observed in the provided ECG.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lateral MI:</strong> This type of MI would show <strong>ST elevations primarily in leads I, aVL, and possibly V5 and V6</strong>, but not in leads V1 to V4.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Posterior MI:</strong> The diagnosis of a posterior MI is typically confirmed by obtaining posterior leads (<strong>V7, V8, and V9) to demonstrate ST elevations</strong>. Alternatively, it can be inferred from <strong>characteristic ST depressions in leads V1 and V2, often with a tall R wave and upright T wave</strong>, which are not seen in this case.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior MI is characterized by ST elevations in leads V1 to V4, with possible involvement of V5 and AVL, and reciprocal ST depressions in leads II, III, and aVF.</span></span></p>",
    "correct_choice_id": 220845,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "FMGE",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11540,
    "choices": [
      {
        "id": 46126,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium oxalate</span></span></span></p>"
      },
      {
        "id": 46127,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium phosphate</span></span></span></p>"
      },
      {
        "id": 46128,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uric acid</span></span></span></p>"
      },
      {
        "id": 46129,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystine</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the urinary crystal shown below? (INICET MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-155713.png\" style=\"height:245px; width:300px\" /></span></span></p>",
    "unique_key": "Q3213675",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965112,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Calcium oxalate</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are typically bipyramidal or envelope-shaped. These crystals are common in various conditions, including hyperoxaluria and ethylene glycol poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B. Calcium phosphate: </strong>&nbsp;crystals form asymmetric rosettes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Uric acid: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;crystals are rhomboid forming rosettes, </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">polychromatophilic in Polarized Microscope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cystine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;crystals are hexagonal, and </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">one of the hardest crystals. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - Monohydrate crystal &ndash; dumbbell shaped</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are bipyramidal or envelope-shaped.</span></span></span></p>",
    "correct_choice_id": 46126,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84269,
    "choices": [
      {
        "id": 335656,
        "text": "<p><span style=\"font-size:12.0pt;\">Fanconi's Anemia</span></p>"
      },
      {
        "id": 335657,
        "text": "<p><span style=\"font-size:12.0pt;\">Paroxysmal Nocturnal Hemoglobinuria (PNH)</span></p>"
      },
      {
        "id": 335658,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypersplenism</span></p>"
      },
      {
        "id": 335659,
        "text": "<p><span style=\"font-size:12.0pt;\">Myelofibrosis</span></p>"
      }
    ],
    "text": "<p>Which of the following anemias is associated with a hypoplastic marrow? (NEET PG 2016)</p>",
    "unique_key": "Q8027345",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965115,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. A) Fanconi's Anemia</strong></p><p>&nbsp;</p><p>Fanconi's anemia is a constitutional form of aplastic anemia associated with hypoplastic bone marrow. It is an inherited disorder characterized by pancytopenia with bone marrow hypocellularity. Fanconi anemia typically presents in early childhood and is often accompanied by characteristic physical anomalies. The disease is caused by mutations in genes involved in DNA repair, leading to genomic instability and progressive bone marrow failure.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Option B. Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>: PNH is an acquired clonal stem cell disorder characterized by intravascular hemolysis. While PNH can be associated with bone marrow failure, it typically presents with a cellular bone marrow rather than hypoplasia. PNH is classified under \"Pancytopenia with Cellular Bone Marrow.\"</li><li><strong>Option C. Hypersplenism</strong>: Hypersplenism refers to the premature destruction or sequestration of blood cells by an enlarged spleen. It is a peripheral cause of cytopenia rather than a primary bone marrow disorder. Hypersplenism is classified under pancytopenia with cellular bone marrow and secondary to systemic diseases.</li><li><strong>Option D. Myelofibrosis</strong>: In myelofibrosis, the bone marrow becomes replaced by fibrous tissue, but it is generally classified as a myeloproliferative disorder with a cellular (not hypoplastic) marrow before the development of fibrosis. Myelofibrosis is listed under pancytopenia with cellular bone marrow.<br><br>&nbsp;</li></ul><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fanconi anemia is a constitutional form of aplastic anemia with hypoplastic bone marrow, while other causes of pancytopenia like PNH, hypersplenism, and myelofibrosis typically present with normal or increased marrow cellularity.</span></p>",
    "correct_choice_id": 335656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11790,
    "choices": [
      {
        "id": 47126,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome</span></span></p>"
      },
      {
        "id": 47127,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle syndrome</span></span></p>"
      },
      {
        "id": 47128,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gitelman syndrome</span></span></p>"
      },
      {
        "id": 47129,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gordon syndrome</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following conditions is associated with hypokalemic metabolic alkalosis with hypertension? (INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q4585263",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965085,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Liddle syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is a genetic disorder characterized by the overactivation of the epithelial sodium channels (ENaC) in the principal cells of the kidneys. This overactivation is due to a gain-of-function mutation in the genes encoding these channels. The increased activity of ENaC leads to excessive reabsorption of sodium and water, causing hypertension. Concurrently, there is increased excretion of potassium and hydrogen ions, which results in hypokalemia and metabolic alkalosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition is often referred to as<strong> pseudo-hyperaldosteronism</strong> because it mimics the effects of aldosterone but without elevated aldosterone levels. The treatment of choice for Liddle syndrome is amiloride, which directly inhibits ENaC channels, unlike spironolactone, which is ineffective in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bartter syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bartter syndrome also presents with hypokalemia and metabolic alkalosis, but patients typically have normal blood pressure. It is a group of autosomal recessive disorders that affect the thick ascending limb of the loop of Henle, mimicking the effects of loop diuretics. Symptoms often present in childhood and may include polyuria, polydipsia, and growth delays. Additionally, patients might have nephrocalcinosis due to increase urinary calcium, recurrent urinary stones, and sometimes sensorineural deafness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gitelman syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gitelman syndrome, like Bartter syndrome, involves hypokalemia and metabolic alkalosis with normal blood pressure. It affects the distal convoluted tubule of the kidney, similar to the action of thiazide diuretics. Patients usually present in adulthood with symptoms such as muscle weakness, cramps, and <strong>tetany due to hypomagnesemia</strong>, which is a significant feature distinguishing it from Bartter syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gordon syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gordon syndrome, or <strong>pseudohypoaldosteronism</strong> type II, is characterized by hypertension and <strong>hyperkalemia, along with metabolic acidosis,</strong> not alkalosis. It results from mutations leading to increased sodium chloride reabsorption in the distal convoluted tubule. Unlike Liddle syndrome, patients with Gordon syndrome exhibit hyperkalemia and acidosis due to chloride retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is characterized by hypokalemic metabolic alkalosis and hypertension due to the overactivation of epithelial sodium channels in the kidneys.</span></span></span></p>",
    "correct_choice_id": 47127,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16163,
    "choices": [
      {
        "id": 64612,
        "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
      },
      {
        "id": 64613,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
      },
      {
        "id": 64614,
        "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
      },
      {
        "id": 64615,
        "text": "<p><span style=\"font-size:12.0pt;\">DC shock</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. ECG is ordered and shown in the image. His temperature is 36.8\u00b0C, PR is 106/min, RR is 18/min, BP is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step? (FMGE JAN 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-091830.png\" alt=\"\" width=\"300\" height=\"171\"></span></p>",
    "unique_key": "Q3226854",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965125,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) DC shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with <strong>atrial fibrillation (AF)</strong> characterized by an <strong>irregularly irregular rhythm and absence of well-defined P waves</strong> on the ECG. His vital signs indicate hemodynamic instability, specifically a low systolic blood pressure of 84 mm Hg (&lt;90 mm HG).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why DC Shock is Correct:</strong> DC shock (synchronized cardioversion) is indicated for patients with tachyarrhythmia who are hemodynamically unstable. Hemodynamic instability is evidenced by a systolic blood pressure below 90 mm Hg, which is a critical threshold indicating the need for immediate cardioversion to restore normal rhythm and improve cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Steps for Decision Making:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Identify the Rhythm:</strong> The ECG shows atrial fibrillation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Assess Stability:</strong> The patient's systolic blood pressure is 84 mm Hg, indicating instability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment Protocol:</strong> Immediate synchronized cardioversion (DC shock) is necessary for unstable tachyarrhythmias.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -&nbsp;</strong>The three contraindications for using synchronized DC cardioversion are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Sinus tachycardia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Multifocal atrial tachycardia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Digitalis toxicity</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heparin</strong>: Heparin is used for anticoagulation in AF to prevent thromboembolism. However, it does not address hemodynamic instability or the immediate need to correct the arrhythmia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Beta blocker</strong>: Beta blockers are used for rate control in stable AF. They are inappropriate for acute management in hemodynamically unstable patients because they can further lower blood pressure and worsen instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Amiodarone</strong>: Amiodarone is an antiarrhythmic that can be used to convert AF to sinus rhythm, but it is not the first-line treatment in an unstable patient. Immediate cardioversion is preferred in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of tachyarrhythmia with hemodynamic instability (e.g., systolic BP &lt; 90 mm Hg), immediate synchronized cardioversion (DC shock) is the treatment of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rule of thumb: \"If the patient is in shock, shock the patient.\"</span></p>",
    "correct_choice_id": 64615,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11593,
    "choices": [
      {
        "id": 46338,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood glucose &lt;40 mg/dL</span></span></span></p>"
      },
      {
        "id": 46339,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial pH &gt;7.2</span></span></span></p>"
      },
      {
        "id": 46340,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum creatinine - 5.2</span></span></span></p>"
      },
      {
        "id": 46341,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unarousable coma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old man presents with 15 days of fever and altered sensorium for 1 day. A rapid diagnostic test was done, and Plasmodium falciparum was diagnosed. Which of the following is not a complication?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q5491345",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965110,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Arterial pH &gt;7.2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An <strong>arterial pH &gt;7.2</strong>, however, is not considered a complication of severe malaria. In fact, severe acidosis is defined by an arterial pH of less than 7.25, and it is a sign of severe malaria. Therefore, an arterial pH &gt;7.2 does not indicate severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Plasmodium falciparum malaria is a severe form of malaria that can lead to numerous complications. The World Health Organization (WHO) defines several criteria for severe malaria, many of which are seen in complicated cases of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blood glucose &lt;40 mg/dL</span></strong><span style=\"font-size:12.0pt\">: Severe hypoglycemia is a known complication of severe malaria, particularly in patients treated with quinine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum creatinine - 5.2</span></strong><span style=\"font-size:12.0pt\">: This indicates severe renal impairment. Serum creatinine levels above 3 mg/dL or reduced urine output despite rehydration are markers of severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Unarousable coma</span></strong><span style=\"font-size:12.0pt\">: Cerebral malaria, which includes unarousable coma or seizures, is one of the most severe complications of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnostic criteria for identifying complicated falciparum malaria, based on clinical and laboratory findings:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arterial pH</span></strong><span style=\"font-size:12.0pt\">: An arterial pH of less than 7.25 is indicative of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bicarbonate Levels</span></strong><span style=\"font-size:12.0pt\">: A bicarbonate level of less than 15 is also a sign of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Base Deficit</span></strong><span style=\"font-size:12.0pt\">: A base deficit of more than 8 is another indicator of severe disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemoglobin</span></strong><span style=\"font-size:12.0pt\">: A hemoglobin level of less than 5, or the presence of hemoglobinuria, are significant markers of severity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Venous Lactate</span></strong><span style=\"font-size:12.0pt\">: A venous lactate level of more than 5 further confirms the complexity and severity of the malaria infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Blood Glucose</span></strong><span style=\"font-size:12.0pt\">: A blood glucose level less than 40 mg/dL is a critical indicator of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Creatinine Levels</span></strong><span style=\"font-size:12.0pt\">: A creatinine level exceeding 3 mg/dL points to significant renal impairment associated with severe malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Urine Output</span></strong><span style=\"font-size:12.0pt\">: A urine output of less than 400 mL per day, despite adequate rehydration with IV fluids, also signifies complicated falciparum malaria.</span></span></span></li>\r\n</ol>",
    "correct_choice_id": 46339,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11799,
    "choices": [
      {
        "id": 47162,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral sumatriptan</span></span></p>"
      },
      {
        "id": 47163,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subcutaneous sumatriptan</span></span></p>"
      },
      {
        "id": 47164,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 6 L/minute</span></span></p>"
      },
      {
        "id": 47165,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 8 L/minute</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment of choice for an acute attack of cluster headache is: (INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q3285611",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965111,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subcutaneous sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Subcutaneous sumatriptan is shown to be effective in treating acute attacks of cluster headaches. The reference indicates that oral sumatriptan is not effective, whereas subcutaneous sumatriptan has been proven beneficial. I</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">ntranasal&nbsp;sumatriptan and intranasal zolmitriptan also are shown to be effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, 100% oxygen therapy at a rate of at least 12 liters per minute is effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral sumatriptan:</span></strong><span style=\"font-size:12.0pt\"> Oral sumatriptan has not been shown to be effective in treating acute cluster headache attacks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 100% oxygen at 6 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Although 100% oxygen is a treatment option, the effective rate is at least 12 liters per minute, making 6 L/minute inadequate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 100% oxygen at 8 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Similar to the previous option, 8 L/minute is below the effective rate of 12 liters per minute required for treating acute cluster headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for an acute attack of cluster headache is subcutaneous sumatriptan, and 100% oxygen therapy should be administered at a rate of at least 12 liters per minute for effectiveness.</span></span></span></p>",
    "correct_choice_id": 47163,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92128,
    "choices": [
      {
        "id": 366828,
        "text": "<p><span style=\"font-size:14.0pt;\">Photosensitivity</span></p>"
      },
      {
        "id": 366829,
        "text": "<p><span style=\"font-size:14.0pt;\">Nephrotic Syndrome</span></p>"
      },
      {
        "id": 366830,
        "text": "<p><span style=\"font-size:14.0pt;\">Arthralgia &amp; Myalgia</span></p>"
      },
      {
        "id": 366831,
        "text": "<p><span style=\"font-size:14.0pt;\">Anemia &amp; Thrombocytopenia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most common clinical feature of systemic lupus erythematosus? (INICET MAY 2025)</span></p>",
    "unique_key": "Q3264953",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965078,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Arthralgia &amp; Myalgia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The most common clinical feature of systemic lupus erythematosus (SLE) is arthralgia and myalgia involving the musculoskeletal system. The musculoskeletal system is the most commonly affected system in SLE, with almost all patients experiencing some form of joint-related symptoms. These manifestations include arthralgia (joint pain), myalgia (muscle pain), and non-erosive polyarthritis. The arthritis in SLE is typically symmetric, polyarticular, and non-erosive in nature, which distinguishes it from rheumatoid arthritis. It is extremely rare to diagnose SLE in a patient who does not have arthralgia, myalgia, or arthritis as part of their clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Manifestations of SLE and Prevalence over the Entire Course of Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ApNNNk3.png\" width=\"994\" height=\"469\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Photosensitivity:</strong> While photosensitivity does occur in SLE and almost every skin lesion in SLE is photosensitive in nature, it is not the most common overall clinical feature. Photosensitivity affects the skin specifically but is not as universally present as musculoskeletal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nephrotic Syndrome:</strong> Nephrotic syndrome can occur in SLE, particularly in lupus nephritis class V (membranous nephropathy), but it affects only a subset of patients with lupus nephritis and is not the most common overall manifestation of SLE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anemia &amp; Thrombocytopenia:</strong> While hematological manifestations do occur in SLE, with anemia being the most common hematological finding (usually anemia of chronic disease or autoimmune hemolytic anemia), and thrombocytopenia can occur as part of Evans syndrome, these are not as universally present as musculoskeletal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The musculoskeletal system is the most commonly affected system in SLE, with arthralgia and myalgia being present in almost all patients with the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xrkr27S.png\" width=\"1161\" height=\"897\"></span></p>",
    "correct_choice_id": 366830,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11579,
    "choices": [
      {
        "id": 46282,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sulfasalazine </span></span></span></p>"
      },
      {
        "id": 46283,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
      },
      {
        "id": 46284,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
      },
      {
        "id": 46285,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is NOT a first-line drug for the management of a patient with rheumatoid arthritis?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q6309258",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965084,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Azathioprine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line drugs for the management of rheumatoid arthritis (RA) are typically Disease-Modifying Antirheumatic Drugs (DMARDs), which include sulfasalazine, hydroxychloroquine, and methotrexate. These drugs are considered core therapies and are often used together in what is known as &quot;triple therapy.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine</span></strong><span style=\"font-size:12.0pt\">, <strong>hydroxychloroquine</strong>, and <strong>methotrexate</strong> are highly effective and commonly used in the treatment of RA. They form the backbone of conventional synthetic DMARDs (csDMARDs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\">, on the other hand, is not a first-line drug for RA management. While it is used in some autoimmune conditions, it is not as effective for RA as the other mentioned drugs. Its efficacy is lower, and it is not commonly included in the standard RA treatment regimens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Sulfasalazine</strong>:<strong> </strong>This drug is a part of the core therapies for RA and is commonly used as a first-line treatment. It is known for its effectiveness and is often used in combination with other DMARDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hydroxychloroquine</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Another key first-line drug for RA, hydroxychloroquine is widely used due to its efficacy and relatively favorable safety profile. It is often part of the triple therapy regimen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Methotrexate</strong>: Methotrexate is considered the cornerstone of RA treatment and is usually the first drug prescribed. It is highly effective and forms the basis of most RA treatment protocols.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine is not a first-line drug for the management of rheumatoid arthritis; the primary first-line drugs are sulfasalazine, hydroxychloroquine, and methotrexate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Hydroxychloroquine</strong> are considered safe for use during pregnancy and are preferred in the management of RA among pregnant patients.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\"> is also somewhat safe during pregnancy, but it is not as effective for RA, so it is less preferred compared to Sulfasalazine and Hydroxychloroquine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Methotrexate&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Leflunomide</strong> are not safe for use during pregnancy and should be avoided due to potential risks to the developing fetus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rheumatoid arthritis management: Range of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-152511.png\" style=\"height:626px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 46285,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11201,
    "choices": [
      {
        "id": 44770,
        "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic DI</span></p>"
      },
      {
        "id": 44771,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary polydipsia</span></p>"
      },
      {
        "id": 44772,
        "text": "<p><span style=\"font-size:12.0pt;\">Pituitary DI</span></p>"
      },
      {
        "id": 44773,
        "text": "<p><span style=\"font-size:12.0pt;\">Mannitol infusion</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with frequent urination, nocturia, and enuresis. 24-hour urine volume was measured and recorded to be 7 liters. The urine osmolarity was 260 mOsm/L. ADH assay was performed and the recorded values were reported as 0.8 pg/mL. An MRI of the brain was performed and T1 weighted indicated the absence of the bright spot. What is the most likely diagnosis? (NEET PG 2018)</span></p>",
    "unique_key": "Q4752231",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965117,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Pituitary DI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of frequent urination, nocturia, and enuresis combined with a large urine output (7 liters) and low urine osmolarity (260 mOsm/L) suggest a deficiency in ADH effect. The low ADH level (0.8 pg/mL) and the absence of the bright spot on T1 weighted MRI (indicative of a pituitary abnormality) further support the diagnosis of Pituitary Diabetes Insipidus (DI). In Pituitary DI, ADH (vasopressin) is not adequately produced by the hypothalamus or released from the posterior pituitary, which leads to reduced water reabsorption in the kidney and subsequent polyuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Approach to Polyuria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Water vs solute diuresis:&nbsp;</strong>(first thing to know)</span></li><li><span style=\"font-size:12.0pt;\">Water diuresis: DI, Primary polydipsia</span></li><li><span style=\"font-size:12.0pt;\"><strong>Solute diuresis:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Glycosuria (Hyperglycemia, SGLT2 inhibitor use)</span></li><li><span style=\"font-size:12.0pt;\">Iatrogenic hyper-osmolar agents (Hypertonic saline, Mannitol, Urea - from high-protein tube feeding, Radiocontrast agents)</span></li><li><span style=\"font-size:12.0pt;\">Salt wasting (e.g., Medullary cystic disease, Diuretics, CSWS, Obstructive uropathy -especially if B/L, resolving ATN)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Before giving desmopressin \u2192 S. Na+ should be 145(or) P. Osm should be &gt; 295.</span></li><li><span style=\"font-size:12.0pt;\">If this cannot be achieved (usually due to severe thirst) during water deprivation - Alternative for water deprivation is Hypertonic saline infusion to achieve S. Na &gt; 145 or P. Osm &gt; 295 - then desmopressin test can be performed.</span></li><li><span style=\"font-size:12.0pt;\">Hypertonic saline (to \u2191P. Osm) + Plasma AVP measurement in response to \u2191 P. Osm due to hypertonic saline. Plasma AVP is unstable and needs stringent storage techniques. Based on AVP levels- can diagnose pituitary vs nephrogenic vs primary polydipsia. Diagnostic accuracy is questionable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm4.jpg\" alt=\"\" width=\"1000\" height=\"594\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**Plasma Co-Peptin&nbsp;</strong>(analogues to C-peptide of insulin) can be used for central vs nephrogenic DI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nephrogenic DI:&nbsp;</strong>Incorrect because it typically involves normal or high levels of ADH, but the kidneys do not respond to it. The patient's ADH is low, making this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Primary polydipsia:&nbsp;</strong>This is associated with excessive fluid intake leading to large volumes of dilute urine but generally will not affect ADH levels significantly, and the brain MRI would typically be normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mannitol infusion:&nbsp;</strong>This causes an osmotic diuresis due to the mannitol not being reabsorbed in the renal tubules. There is no evidence of mannitol administration in the patient's history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>MMS algorithm for finding out the cause</u></strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/17/untitled-403.jpg\" alt=\"\" width=\"1000\" height=\"426\"></span></p>",
    "correct_choice_id": 44772,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11303,
    "choices": [
      {
        "id": 45178,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></p>"
      },
      {
        "id": 45179,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin 150mg</span></span></p>"
      },
      {
        "id": 45180,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral warfarin</span></span></p>"
      },
      {
        "id": 45181,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin + Clopidogrel</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old woman presents with breathlessness and chest pain. She is a known case of mitral stenosis. Her pulse is irregularly irregular. No thrombus is seen on echocardiography. What can be done to prevent future thrombotic events?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
    "unique_key": "Q2430087",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965120,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Oral warfarin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is diagnosed with mitral stenosis and has an irregularly irregular pulse, indicating atrial fibrillation (AF). Atrial fibrillation is a common complication in patients with mitral stenosis and significantly increases the risk of thromboembolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Long-term anticoagulation therapy is essential in such patients to prevent these events. The presence of mitral stenosis, particularly moderate to severe, mandates the use of oral anticoagulants. Warfarin is the recommended anticoagulant in this scenario because it is the only approved medication for patients with mitral stenosis and those with mechanical prosthetic heart valves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other anticoagulants, such as Direct Oral Anticoagulants (DOACs), are not recommended in patients with valvular atrial fibrillation (AF associated with mitral stenosis or mechanical heart valves).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information &ndash;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CHA2DS2-VASc score</span></strong><span style=\"font-size:12.0pt\"> to guide anticoagulation therapy in patients without mitral stenosis or a prosthetic valve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">C</span></strong><span style=\"font-size:12.0pt\"> - Congestive heart failure: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">H</span></strong><span style=\"font-size:12.0pt\"> - Hypertension: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A</span></strong><span style=\"font-size:12.0pt\"> - Age 65 to 74: 1 point, Age 75 and above: 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">D</span></strong><span style=\"font-size:12.0pt\"> - Diabetes Mellitus: 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">S2</span></strong><span style=\"font-size:12.0pt\"> - Prior stroke or TIA: 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sex category</span></strong><span style=\"font-size:12.0pt\"> (Female): 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vascular diseases</span></strong><span style=\"font-size:12.0pt\"> (such as coronary artery disease or peripheral artery disease): 1 point</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Scoring and Treatment Recommendations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Total Points</span></strong><span style=\"font-size:12.0pt\">: Ranges from 0 to 9.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Score of 2 or more</span></strong><span style=\"font-size:12.0pt\">: Strongly indicates the need for long-term anticoagulation (DOAC &gt; warfarin).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Direct Oral Anticoagulants (DOACs)</span></strong><span style=\"font-size:12.0pt\"> such as Dabigatran, Apixaban, Rivaroxaban, or Edoxaban are preferred unless the patient has conditions like mitral stenosis or mechanical prosthetic valves, in which case Warfarin might be more appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Score less than 2</span></strong><span style=\"font-size:12.0pt\">: Anticoagulation may be considered but is less mandatory.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This scoring system is crucial for making informed decisions about anticoagulation therapy to prevent stroke in patients with atrial fibrillation, tailoring treatment based on individual risk profiles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dabigatran:</span></strong><span style=\"font-size:12.0pt\"> Dabigatran is a DOAC that is not recommended for patients with mitral stenosis or mechanical heart valves. It is suitable for non-valvular atrial fibrillation but not for valvular AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Aspirin 150mg:</span></strong><span style=\"font-size:12.0pt\"> Aspirin is not sufficient as an anticoagulant in patients with atrial fibrillation, especially those with mitral stenosis. It does not provide the necessary anticoagulation to prevent thromboembolic events in such high-risk patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspirin + Clopidogrel:</span></strong><span style=\"font-size:12.0pt\"> This combination is also inadequate for anticoagulation in atrial fibrillation, particularly in patients with mitral stenosis. While it can prevent platelet aggregation, it does not provide the anticoagulation required to prevent thrombus formation in atrial fibrillation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with atrial fibrillation associated with mitral stenosis, oral warfarin is the recommended anticoagulant to prevent thromboembolic events.</span></span></p>",
    "correct_choice_id": 45180,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74875,
    "choices": [
      {
        "id": 298401,
        "text": "<p><span style=\"font-size:16px;\">Encephalitis</span></p>"
      },
      {
        "id": 298402,
        "text": "<p><span style=\"font-size:16px;\">Acute severe ulcerative colitis</span></p>"
      },
      {
        "id": 298403,
        "text": "<p><span style=\"font-size:16px;\">ARDS</span></p>"
      },
      {
        "id": 298404,
        "text": "<p><span style=\"font-size:16px;\">Acute pancreatitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">The Truelove and Witt criteria are used for assessing which of the following conditions? (INICET NOV 2024)</span></p>",
    "unique_key": "Q5762798",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965079,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Acute severe ulcerative colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The Truelove and Witt criteria are specifically used for assessing the severity of ulcerative colitis. These criteria help classify the disease into mild, moderate, or severe categories.</span></p><p><br><span style=\"font-size:16px;\">Another set of criteria called the Travis criteria is used to assess treatment response and predict the risk of progression to surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Encephalitis:</strong> Incorrect because encephalitis has its own specific diagnostic criteria and severity assessment tools that focus on neurological symptoms and findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. ARDS:</strong> Incorrect because ARDS is diagnosed and classified using the Berlin criteria (2012), which primarily use the P/F ratio (PaO2/FiO2) with a PEEP of at least 5 cm H2O.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Acute pancreatitis:</strong> Incorrect because acute pancreatitis has scoring systems for severity assessment, such as Ranson's criteria or the APACHE II score.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Truelove and Witt criteria are used for assessing the severity of ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Truelove and Witt's Criteria for Severity of Ulcerative Colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TjxPFrg.png\" width=\"759\" height=\"348\"></strong></span></p>",
    "correct_choice_id": 298402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24763,
    "choices": [
      {
        "id": 99013,
        "text": "<p><span style=\"font-size:11.0pt;\">2, 4 only</span></p>"
      },
      {
        "id": 99014,
        "text": "<p><span style=\"font-size:11.0pt;\">1, 3 only</span></p>"
      },
      {
        "id": 99015,
        "text": "<p><span style=\"font-size:11.0pt;\">1, 2 ,3,4</span></p>"
      },
      {
        "id": 99016,
        "text": "<p><span style=\"font-size:11.0pt;\">1, 2, 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe vomiting and diarrhea and has orthostatic hypotension. What metabolic abnormalities would you expect in this patient? (INICET MAY 2023)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1.Hypokalemia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2.Hypochloremia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3.Metabolic alkalosis</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4.Respiratory alkalosis</span></p>",
    "unique_key": "Q8200355",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965108,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe vomiting and diarrhea can lead to multiple metabolic abnormalities: Hypokalemia, Hypochloremia, metabolic alkalosis with hyponatremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. <strong>Hypokalemia</strong>: Loss of potassium through vomiting and diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2. <strong>Hypochloremia</strong>: Loss of chloride.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">3.<strong> Metabolic alkalosis</strong>: Loss of gastric acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These changes are due to the loss of electrolytes and fluids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">4. <strong>Respiratory alkalosis </strong>involves hyperventilation and a decrease in carbon dioxide, which is unrelated to the described condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe vomiting and diarrhea typically cause hypokalemia, hypochloremia, and metabolic alkalosis.</span></p>",
    "correct_choice_id": 99016,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74876,
    "choices": [
      {
        "id": 298405,
        "text": "<p><span style=\"font-size:16px;\">Chest X-ray findings</span></p>"
      },
      {
        "id": 298406,
        "text": "<p><span style=\"font-size:16px;\">Raised Trop T level</span></p>"
      },
      {
        "id": 298407,
        "text": "<p><span style=\"font-size:16px;\">CCF</span></p>"
      },
      {
        "id": 298408,
        "text": "<p><span style=\"font-size:16px;\">Diastolic murmur</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Nadas criteria include all of the following except:&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q4652029",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965105,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Raised Trop T level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Nadas criteria, proposed by Hungarian cardiologist Dr. Alexander Nadas in the 1950s\u201360s, are used for diagnosing congenital heart disease. The criteria require at least one major and two minor criteria for diagnosis. Major criteria include systolic murmur grade 3-4/6, diastolic murmur, presence of congestive heart failure, and cyanosis. Minor criteria include grade 2/6 systolic murmur, abnormal S2, abnormal chest X-ray, abnormal ECG, and abnormal blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Nadas criteria are used for diagnosing congenital heart disease, which includes both major criteria (systolic murmur grade 3-4/6, diastolic murmur, CCF, cyanosis) and minor criteria (grade 2/6 systolic murmur, abnormal S2, abnormal X-ray, abnormal ECG, abnormal BP).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ke331nr.png\" width=\"760\" height=\"218\"></strong></span></p>",
    "correct_choice_id": 298406,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47603,
    "choices": [
      {
        "id": 190023,
        "text": "<p><span style=\"font-size:12.0pt;\">Electrical alternans</span></p>"
      },
      {
        "id": 190024,
        "text": "<p><span style=\"font-size:12.0pt;\">Atrial tachycardia</span></p>"
      },
      {
        "id": 190025,
        "text": "<p><span style=\"font-size:12.0pt;\">First degree AV block</span></p>"
      },
      {
        "id": 190026,
        "text": "<p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An old man has recurrent fainting episodes. His ECG shows P-waves at 75/min, QRS complexes are at 35 bpm. The clinical diagnosis is:&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q6682207",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965101,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Stokes-Adams Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has recurrent fainting episodes, and his ECG shows a discrepancy between the rate of P-waves (75/min) and QRS complexes (35 bpm), indicating an AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the P-waves are getting blocked at the AV node, leading to fewer QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome refers to recurrent fainting/ syncopal episodes caused by sudden fluctuations in cardiac output, paroxysmal Bradycardia often due to AV blocks such as complete heart block or second-degree AV block (Mobitz type II).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Electrical alternans:&nbsp;</strong>This is seen in cardiac tamponade and is characterized by beat-to-beat variations in QRS amplitude or axis. The patient would present with signs of tamponade such as hypotension, muffled heart sounds, and jugular venous distension, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atrial tachycardia:&nbsp;</strong>This would present with a ventricular response rate of more than 100 bpm and would typically involve abnormal P-wave morphology. The patient in this case has bradycardia (QRS at 35 bpm), excluding atrial tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree AV block:&nbsp;</strong>This is characterized by a prolonged PR interval with a 1:1 P to QRS ratio. The discrepancy between P-wave and QRS complex rates in this case excludes first degree AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stokes-Adams Syndrome involves recurrent fainting episodes due to sudden changes in cardiac output, typically from AV block-related bradycardia. Recognizing the discrepancy between atrial and ventricular rates is crucial for diagnosis.</span></p>",
    "correct_choice_id": 190026,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24762,
    "choices": [
      {
        "id": 99009,
        "text": "<p><span style=\"font-size:11.0pt;\">Azithromycin</span></p>"
      },
      {
        "id": 99010,
        "text": "<p><span style=\"font-size:11.0pt;\">Ceftriaxone plus azithromycin</span></p>"
      },
      {
        "id": 99011,
        "text": "<p><span style=\"font-size:11.0pt;\">Amoxicillin plus clavulanic acid</span></p>"
      },
      {
        "id": 99012,
        "text": "<p><span style=\"font-size:11.0pt;\">Piperacillin Tazobactam plus ciprofloxacin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A patient in emergency has the following lab parameters: creatinine 1.5 and BUN 45. The chest x-ray is shown below. In gram staining and culture only, rhinovirus was isolated. The patient is shifted to ICU. What is the treatment of choice in this patient? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am_uLaNUaB.jpeg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
    "unique_key": "Q9499007",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965082,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Ceftriaxone plus azithromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient is diagnosed with <strong>community-acquired pneumonia (CAP)</strong> and has been shifted to the ICU. The treatment of choice for ICU-admitted patients with CAP includes a <strong>beta-lactam antibiotic</strong> like beta-lactam/beta-lactamase inhibitor (BL/BLI) combination like amoxicillin-clavulanic acid or piperacillin-tazobactam, or a third-generation cephalosporin like ceftriaxone combined with azithromycin or a respiratory fluoroquinolone such as levofloxacin or moxifloxacin should be administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ceftriaxone are used to cover typical bacteria, while azithromycin covers atypical bacteria and provides additional anti-inflammatory properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Azithromycin</strong>: Insufficient as monotherapy in ICU settings.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amoxicillin plus clavulanic acid:</strong> Lacks coverage for atypical pathogens alone.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Piperacillin Tazobactam plus ciprofloxacin</strong>: Ciprofloxacin is not a respiratory fluoroquinolone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The combination of a beta-lactam antibiotic and azithromycin is the treatment of choice for ICU-admitted patients with community-acquired pneumonia.</span></p>",
    "correct_choice_id": 99010,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11269,
    "choices": [
      {
        "id": 45042,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal dysmotility</span></span></span></span></p>"
      },
      {
        "id": 45043,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myopathy</span></span></span></span></p>"
      },
      {
        "id": 45044,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial lung disease</span></span></span></span></p>"
      },
      {
        "id": 45045,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma renal crisis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is more common in limited cutaneous systemic sclerosis when compared to diffuse cutaneous systemic sclerosis? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2481241",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965119,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Esophageal dysmotility</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal dysmotility is more commonly associated with limited cutaneous systemic sclerosis (lcSSc), particularly as part of the CREST syndrome (Calcinosis, Raynaud&#39;s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia). This condition involves abnormalities in the motility of the esophagus, which can lead to difficulties in swallowing and gastroesophageal reflux.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Myopathy:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While myopathy can occur in systemic sclerosis, it is not specifically more common in limited cutaneous systemic sclerosis compared to the diffuse type.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Interstitial lung disease (ILD):</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> ILD is actually more commonly associated with diffuse cutaneous systemic sclerosis due to broader and more aggressive skin involvement and higher prevalence of specific autoantibodies like Anti-Scl-70 (anti-topoisomerase).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Scleroderma renal crisis:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a severe complication more frequently seen in diffuse cutaneous systemic sclerosis, particularly in the early stages of the disease, often exacerbated by the use of corticosteroids.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-191513.jpg\" style=\"height:588px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/ Chap 360</span></span></strong></span></span></p>",
    "correct_choice_id": 45042,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11522,
    "choices": [
      {
        "id": 46054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus Niger - Voriconazole</span></span></span></p>"
      },
      {
        "id": 46055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus fumigatus - Micafungin</span></span></span></p>"
      },
      {
        "id": 46056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida albicans - Amphotericin B</span></span></span></p>"
      },
      {
        "id": 46057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida Krusei&ndash; Fluconazole</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the correct &#39;organism-drug to which it is intrinsically resistant&#39; pair: (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q4740923",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965086,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Candida Krusei- Fluconazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is known to be intrinsically resistant to fluconazole, which is a widely used antifungal agent. This resistance is due to the specific genetic and biochemical characteristics of C. Kruse, which include efflux pumps that actively expel the drug and alterations in the target enzyme of fluconazole, making it less effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Aspergillus Niger - Voriconazole:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus Niger is not intrinsically resistant to voriconazole; in fact, voriconazole is one of the treatments of choice for Aspergillus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Aspergillus fumigatus - Micafungin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus fumigatus is sensitive to echinocandins, including micafungin. It is not intrinsically resistant to this drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Candida albicans - Amphotericin B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Candida albicans is sensitive to amphotericin B, which is a broad-spectrum antifungal with a wide range of activity against various fungal species.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is intrinsically resistant to fluconazole.</span></span></span></p>",
    "correct_choice_id": 46057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92132,
    "choices": [
      {
        "id": 366844,
        "text": "<p><span style=\"font-size:14.0pt;\">Sensory Disturbances</span></p>"
      },
      {
        "id": 366845,
        "text": "<p><span style=\"font-size:14.0pt;\">Vertigo</span></p>"
      },
      {
        "id": 366846,
        "text": "<p><span style=\"font-size:14.0pt;\">Ataxia</span></p>"
      },
      {
        "id": 366847,
        "text": "<p><span style=\"font-size:14.0pt;\">Facial Palsy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most common/earliest presenting symptom in patients with Multiple Sclerosis? (INICET MAY 2025)</span></p>",
    "unique_key": "Q1934879",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965104,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sensory Disturbances</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sensory disturbances are the most common and earliest presenting symptom in patients with Multiple Sclerosis (MS). According to clinical data, approximately 60% of patients (almost two-thirds) present with some form of sensory disturbance or sensory issue as their initial manifestation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These sensory symptoms typically include numbness, loss of vibration sensation, loss of proprioception, and other sensory deficits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After sensory disturbances, optic neuritis is the second most common initial manifestation, affecting approximately 20-40% of patients at presentation, though up to 50% develop it during the course of their illness.</span></p><p><br><br><span style=\"font-size:14.0pt;\"><strong>Initial Symptoms of Multiple Sclerosis (MS)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ifwKZ9o.png\" width=\"1282\" height=\"456\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vertigo:</strong> Vertigo due to cerebellar involvement can occur in MS but is much less common than sensory disturbances, affecting only about 11% of patients at presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ataxia:</strong> Ataxia due to cerebellar involvement occurs in approximately 6% of patients at presentation, making it significantly less common than sensory disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Facial Palsy:</strong> Facial palsy is quite rare as an initial presentation of MS, occurring in approximately only 1% of patients. This is due to involvement of corticobulbar fibers but is not a common initial finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Multiple Sclerosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">MC degenerative disease</span></li><li><span style=\"font-size:14.0pt;\">\u2640:&nbsp;\u2642 = 3:1, HLADRB1 association, linked to vitamin D deficiency &amp; EBV</span></li><li><span style=\"font-size:14.0pt;\">Clinical patterns: RRMS (MC, most progresses to SPMS), PPMS, PRPS</span></li><li><span style=\"font-size:14.0pt;\">Presentation: Sensory (MC)- numbness/loss of vibration/proprioception, optic (UMN)- spasticity/bladder dysfunction, vision loss, diplopia, ataxia, vertigo</span></li><li><span style=\"font-size:14.0pt;\">Charcot's Triad - Intentional tremors, Nystagmus &amp; Staccato speech</span></li><li><span style=\"font-size:14.0pt;\">Can have associated Lhermitte's sign, Uhthoff phenomenon (heat intolerance) &amp; Pulfrich effect</span></li><li><span style=\"font-size:14.0pt;\">Uncommon in MS: Visual field defects, Aphasia, Apraxia, progressive hemiparesis</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis: Revised McDonald's criteria (2017) - DIS + DIT (gold standard = MRI)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_crV0oK1.png\" width=\"1140\" height=\"334\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">MS variants: Marburg variant, Tumefactive MS</span></li><li><span style=\"font-size:14.0pt;\">Management: Acute attack - CS/PEX, Chronic Rx: DMDs (\u2193duration of acute attack)</span></li></ul>",
    "correct_choice_id": 366844,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47519,
    "choices": [
      {
        "id": 189687,
        "text": "<p><span style=\"font-size:12.0pt;\">15 mg</span></p>"
      },
      {
        "id": 189688,
        "text": "<p><span style=\"font-size:12.0pt;\">12 mg</span></p>"
      },
      {
        "id": 189689,
        "text": "<p><span style=\"font-size:12.0pt;\">8 mg</span></p>"
      },
      {
        "id": 189690,
        "text": "<p><span style=\"font-size:12.0pt;\">10 mg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with an acute ischemic stroke is undergoing thrombolysis with IV alteplase. He currently weighs 80 kg. What is the appropriate dose of alteplase to be given to this patient?&nbsp;</span>(FMGE JULY 2023)</p>",
    "unique_key": "Q7372585",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965126,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 8 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The appropriate dose of IV alteplase (recombinant tissue plasminogen activator, rtPA) for a patient with acute ischemic stroke is 0.9 mg/kg. The total dose for an 80 kg patient would be approximately 72 mg (0.9 mg/kg x 80 kg = 72 mg). According to the standard administration protocol:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">10% of the total dose is given as an initial bolus over 1 minute.</span></li><li><span style=\"font-size:12.0pt;\">The remaining 90% is infused over 1 hour.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For this patient:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total dose = 72 mg.</span></li><li><span style=\"font-size:12.0pt;\">Bolus dose = 10% of 72 mg = 7.2 mg, rounded to 8 mg.</span></li><li><span style=\"font-size:12.0pt;\">The remaining dose (64.8 mg \u2248 64 mg) is given as a continuous infusion over 1 hour.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, the initial bolus dose of alteplase for this patient is 8 mg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient weighing 80 kg, the appropriate initial bolus dose of alteplase for acute ischemic stroke is 8 mg, followed by the remainder of the dose given as an infusion over 1 hour.</span></p>",
    "correct_choice_id": 189689,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11240,
    "choices": [
      {
        "id": 44926,
        "text": "<p><span style=\"font-size:12.0pt;\">IV verapamil</span></p>"
      },
      {
        "id": 44927,
        "text": "<p><span style=\"font-size:12.0pt;\">IV adenosine</span></p>"
      },
      {
        "id": 44928,
        "text": "<p><span style=\"font-size:12.0pt;\">Carotid massage</span></p>"
      },
      {
        "id": 44929,
        "text": "<p><span style=\"font-size:12.0pt;\">Synchronized cardioversion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old female patient is brought to the ER in a state of unconsciousness. Her BP is 70/50 mm of Hg and her ECG is shown below. What is the next best step in the management of her condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-144116.png\" alt=\"\" width=\"400\" height=\"203\"></p>",
    "unique_key": "Q6475864",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965092,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Synchronized cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Any <strong>hemodynamically unstable rhythm, requires synchronized cardioversion</strong> (Shock delivered in sync with R wave <strong>to prevent R-on-T phenomenon</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong>AV Nodal blockers are used if <i>hemodynamically stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Maximum of 30mg of adenosine can be tried if patient is <i>Hemodynamically Stable.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Carotid massage is not recommended for hemodynamically unstable patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110009.jpg\" alt=\"\" width=\"1000\" height=\"353\"></strong></span></p>",
    "correct_choice_id": 44929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50947,
    "choices": [
      {
        "id": 203329,
        "text": "<p><span style=\"font-size:12.0pt;\">Total T3&nbsp;</span></p>"
      },
      {
        "id": 203330,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroid scan&nbsp;</span></p>"
      },
      {
        "id": 203331,
        "text": "<p><span style=\"font-size:12.0pt;\">Free T4&nbsp;</span></p>"
      },
      {
        "id": 203332,
        "text": "<p><span style=\"font-size:12.0pt;\">TSH&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female patient presents with weight loss, anxiety, tachycardia, and restlessness. The resting pulse was 110 beats per minute. Which of the following tests should be done next to evaluate her condition further? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023</span><span style=\"font-size:12.0pt;\">)</span></p>",
    "unique_key": "Q4137222",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965107,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TSH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">In the evaluation of suspected thyroid dysfunction, the initial and most crucial test is the measurement of Thyroid-Stimulating Hormone (TSH). TSH is the most sensitive indicator of thyroid function because even minor changes in thyroid hormone levels cause significant changes in TSH levels due to the feedback mechanism between the thyroid gland and the pituitary gland. Elevated or suppressed TSH levels provide clear insight into whether the thyroid gland is underactive (hypothyroidism) or overactive (hyperthyroidism). Given the patient's symptoms of weight loss, anxiety, tachycardia, and restlessness, hyperthyroidism is suspected, making TSH the appropriate initial test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. &nbsp;Total T3:</strong>&nbsp;T3 levels can be influenced by various factors and are usually measured after initial TSH and Free T4 tests suggest hyperthyroidism.</span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &nbsp;Thyroid Scan:&nbsp;</strong>This imaging test evaluates thyroid structure and function, useful in cases where nodules or hyperactivity need to be assessed. It is not the first-line test for evaluating general thyroid function.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Free T4:&nbsp;</strong>Free T4 is important in assessing thyroid function and is typically measured alongside TSH. However, TSH is preferred as the initial screening test due to its sensitivity in detecting thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial test for evaluating suspected thyroid dysfunction, particularly in hyperthyroid symptoms, is TSH due to its sensitivity and reliability in reflecting thyroid status.</span></p>",
    "correct_choice_id": 203332,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20251,
    "choices": [
      {
        "id": 80965,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
      },
      {
        "id": 80966,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral Regurgitation</span></p>"
      },
      {
        "id": 80967,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
      },
      {
        "id": 80968,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic Stenosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Among the given options, murmur given in the image is associated with? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/whatsapp-image-2023-06-12-at-1901276.jpg\" alt=\"\" width=\"400\" height=\"70\"></span></p>",
    "unique_key": "Q7877972",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965122,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Mitral Regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided indicates a murmur occurring between S1 and S2, which is described as <strong>a pan-systolic murmur</strong>. This type of murmur spans the entirety of systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mitral Regurgitation</strong> produces a pan-systolic murmur due to the backward flow of blood from the left ventricle into the left atrium throughout systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic Regurgitation:</strong> Characterized by an <strong>early diastolic murmur</strong> due to backflow of blood from the aorta into the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Stenosis:</strong> Characterized by a <strong>mid-diastolic murmur</strong> due to obstructed blood flow from the left atrium to the left ventricle during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aortic Stenosis:</strong> Characterized by an <strong>ejection systolic murmur</strong> due to turbulent blood flow across a narrowed aortic valve during systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitral regurgitation is associated with a pan-systolic murmur, which is present throughout the systole and heard between the S1 and S2 heart sounds.</span></p>",
    "correct_choice_id": 80966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54256,
    "choices": [
      {
        "id": 216493,
        "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
      },
      {
        "id": 216494,
        "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
      },
      {
        "id": 216495,
        "text": "<p><span style=\"font-size:12.0pt;\">Posterior MI</span></p>"
      },
      {
        "id": 216496,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute Myocarditis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presented with chest pain and shortness of breath. An ECG was taken in the emergency and was shown. What is the likely diagnosis?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101157.jpg\" alt=\"\" width=\"500\" height=\"234\"></span></p>",
    "unique_key": "Q7254253",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965080,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Posterior MI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows classic signs of a posterior myocardial infarction (MI). The characteristic features of posterior MI in<strong> leads V1, V2 and (\u00b1) V3 include a</strong> <strong>tall R wave, ST depression, and upright T wave.</strong> These features suggest a mirror image of an infarction in the posterior wall of the left ventricle. While definitive diagnosis of a posterior MI typically involves additional leads (V7, V8, V9), the observed patterns in leads V2 and V3 are indicative of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided case, the absence of ST elevation rules out an acute STEMI. NSTEMI and unstable angina can only be differentiated by cardiac biomarkers such as troponins, which are not mentioned here. Acute myocarditis would typically present with non-specific ECG changes and a relevant clinical history, such as a recent viral infection, which is not present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NSTEMI:</strong>&nbsp; NSTEMI (Non-ST Elevation Myocardial Infarction) can present with similar symptoms but requires positive cardiac troponins for diagnosis. The absence of troponin data makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Unstable Angina: </strong>Unstable angina presents with similar symptoms but without elevation of cardiac biomarkers. As mentioned, differentiating between NSTEMI and unstable angina is not possible without troponin levels, which are not provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Myocarditis:</strong> Acute myocarditis would typically present with a history of viral infection and can show non-specific ECG changes, often including sinus tachycardia. The patient's history and ECG findings do not support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of tall R waves, ST depression, and upright T waves in leads V2 and V3 are indicative of a posterior myocardial infarction.</span></p>",
    "correct_choice_id": 216495,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 49324,
    "choices": [
      {
        "id": 196863,
        "text": "<p>Antibody assay</p>"
      },
      {
        "id": 196864,
        "text": "<p>P24 antigen assay</p>"
      },
      {
        "id": 196865,
        "text": "<p>Nucleic acid test (NAT)</p>"
      },
      {
        "id": 196866,
        "text": "<p>Polymerase chain reaction (PCR)</p>"
      }
    ],
    "text": "<p>Which of the following tests has the briefest window period for identifying HIV infection? (NEET PG 2015)</p>",
    "unique_key": "Q7518384",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965088,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: C. Nucleic acid test (NAT)</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Nucleic acid tests (NATs) have the shortest window period for detecting HIV infection, typically identifying the virus 10-12 days after infection. NATs directly detect viral RNA in the bloodstream rather than waiting for the development of antibodies or sufficient levels of viral proteins. This makes them extremely valuable for detecting very early HIV infections, particularly in high-risk settings or when testing blood donations.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Antibody assay</strong>: Antibody tests have a significantly longer window period of approximately 3-12 weeks after infection, as they depend on the host's immune response to produce detectable antibodies against HIV. While they are the most commonly used screening tests due to cost and availability, they cannot detect very early infections.</p><p>&nbsp;</p><p><strong>Option B. P24 antigen assay</strong>: The p24 antigen test detects the HIV p24 protein and has a window period of about 2-3 weeks after infection. While shorter than antibody tests, it's still longer than NAT. The p24 antigen is often combined with antibody testing in 4th generation assays.</p><p>&nbsp;</p><p><strong>Option D. Polymerase chain reaction (PCR</strong>): PCR is actually a type of nucleic acid testing technology used to detect HIV RNA or proviral DNA. When used for HIV RNA detection, it performs similarly to other NATs. This option represents a specific methodology rather than a distinct test category.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Nucleic acid tests have the shortest window period (10-12 days) for HIV detection and are the most sensitive for early infection, but antibody-based tests remain the mainstay for routine screening due to cost and availability considerations.</p>",
    "correct_choice_id": 196865,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11347,
    "choices": [
      {
        "id": 45354,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. long-acting insulin</span></p>"
      },
      {
        "id": 45355,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. regular insulin</span></p>"
      },
      {
        "id": 45356,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous insulin I.V. long-acting insulin</span></p>"
      },
      {
        "id": 45357,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with I.V. regular insulin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management? (Neet pg 2022)</span></p>",
    "unique_key": "Q2295940",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965095,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Intravenous fluids with I.V. regular insulin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with diabetic ketoacidosis (DKA), the immediate management involves <strong>FLIP Therapy (fluid resuscitation, insulin therapy and Potassium management)</strong>. This patient's blood glucose is significantly elevated, and the presence of ketones indicates DKA, which is a medical emergency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Fluids</strong>: The initial step is to administer intravenous (IV) fluids to correct dehydration and stabilize the patient's hemodynamic status. The typical approach involves giving isotonic saline (0.9% sodium chloride) at a <strong>rate of 10-20 mL/kg/hr (2-3L) for the first 2-3 hours</strong>. This helps to correct hypovolemia, improve perfusion, and begin to lower blood glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for fluid management</strong>: After the initial two to three hours of treatment, switch from initial fluids (typically normal saline) to half normal saline for ongoing maintenance.&nbsp;If capillary blood glucose (CBG) drops below 300 mg/dL, and specifically if it falls below 250 mg/dL, add 5% dextrose water to the regimen.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The purpose of adding dextrose is to maintain a target CBG range of 200 to 300 mg/dL. This range helps prevent hypoglycemia, which is a critical concern in the management process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Insulin</strong>: Insulin therapy is crucial to halt ketogenesis and reduce blood glucose levels. After 1 hr of fluid start insulin. The <strong>recommended protocol for DKA involves IV regular insulin</strong> because of its rapid onset and short duration of action. The insulin regimen follows a fixed dose insulin infusion (FDII) approach. This helps to normalize blood glucose and ketone levels efficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">First option: Continuous infusion at 0.15 units/kg/hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Second option (<strong>more commonly used</strong>): Administer a 0.1 units/kg bolus, followed by a 0.1 units/kg/hour infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IV regular insulin</strong> is preferred over subcutaneous (SC) insulin in emergency settings like DKA due to its predictable absorption and ability to be titrated easily based on frequent blood glucose monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adjustments Based on Blood Glucose Levels</strong>: Monitor capillary blood glucose (CBG). If CBG drops below 300 mg/dL, reduce the insulin infusion to half the dose (0.05 units/kg/hour).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for Stopping Insulin Infusion</strong>: Insulin infusion can be stopped ONLY when the patient tolerates oral feeds without vomiting or abdominal pain. Other criteria include resolution of ketoacidosis, negative or trace positive plasma ketones, and an <strong>anion gap less than 12</strong>, pH more than 7.3 and serum bicarbonate more than 18.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Transition to subcutaneous insulin upon meeting these criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potassium</strong> Management: Potassium addition is tailored based on serum potassium levels. When serum potassium levels are within a normal range, add approximately 40 milliequivalents of potassium chloride (KCL) per liter of IV fluid administered. This ensures adequate potassium levels to prevent hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Monitoring</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If serum potassium is below 3.3, administer IV potassium chloride (KCL) before insulin to prevent hypokalemia-induced arrhythmias.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium is between 3.3 and 5.2, administer insulin and KCL together.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium exceeds 5.3 &amp; above, administer insulin without KCL and monitor serum potassium closely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment Goals and Precautions</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Aim for a target CBG of 200 to 300 mg/dL to avoid hypoglycemia.</span></li><li><span style=\"font-size:12.0pt;\">The common causes of death in patients with DKA, particularly during the treatment phase \u2013&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Cerebral edema</strong> (MC) may occur due to a rapid decrease in blood glucose levels, which can lead to an osmotic shift. This shift causes fluids to move from the extracellular fluid (ECF) to the intracellular fluid (ICF), resulting in swelling of the brain tissue.</span></li><li><span style=\"font-size:12.0pt;\">2<sup>nd</sup> MC cause is <strong>Potassium Disorder</strong> esp. Hypokalemia, this can result in ventricular arrythmias.</span></li><li><span style=\"font-size:12.0pt;\">Other causes include ARDS, patients can initially develop acute kidney injury (pre-renal), later if severe, leads to ATN (Acute tubular necrosis) due to hypoperfusion of kidneys.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Intravenous fluids with S.C. long-acting insulin</strong>: Long-acting insulin is not suitable for acute management due to its prolonged action and delayed onset, making it inappropriate for rapid correction of hyperglycemia and ketonemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intravenous fluids with S.C. regular insulin</strong>: While regular insulin is appropriate, the subcutaneous route is less effective in severe DKA where IV administration allows for better control and titration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Intravenous insulin I.V. long-acting insulin</strong>: Long-acting insulin is never administered IV due to the risk of prolonged hypoglycemia and lack of titratability. It is also not designed for acute management settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of diabetic ketoacidosis (DKA), the initial steps involve aggressive IV fluid resuscitation followed by IV regular insulin to rapidly lower blood glucose and resolve ketosis.</span></p>",
    "correct_choice_id": 45357,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47514,
    "choices": [
      {
        "id": 189667,
        "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnea</span></p>"
      },
      {
        "id": 189668,
        "text": "<p><span style=\"font-size:12.0pt;\">Narcolepsy</span></p>"
      },
      {
        "id": 189669,
        "text": "<p><span style=\"font-size:12.0pt;\">Obesity hypoventilation syndrome</span></p>"
      },
      {
        "id": 189670,
        "text": "<p><span style=\"font-size:12.0pt;\">Central sleep apnea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female presents with daytime sleepiness, impaired concentration, and impaired memory. On exam, her BMI is 43, BP is 170/100 mm Hg. Her daytime ABG analysis shows HCO3 - 33 mEq/L, PaCO2 - 53 mmHg, and PaO2 - 70 mmHg. What is the most likely diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
    "unique_key": "Q9785874",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965100,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Obesity hypoventilation syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has obesity hypoventilation syndrome (OHS), which is characterized by the following criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A BMI of 30 or more, indicating obesity.</span></li><li><span style=\"font-size:12.0pt;\">Hypercarbia or hypercapnia, defined as PaCO2 &gt; 45 mm Hg.</span></li><li><span style=\"font-size:12.0pt;\">The awake ABG must be taken (daytime ABG).</span></li><li><span style=\"font-size:12.0pt;\">No other causes (central or peripheral neuromuscular) should be present to explain the hypercapnia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and test results align with OHS. OHS patients typically present with symptoms like daytime sleepiness, impaired concentration, and impaired memory, which are noted in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Obstructive sleep apnea:</strong> This condition typically causes issues during sleep, not in the daytime. It is characterized by repeated episodes of partial or complete upper airway obstruction during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Narcolepsy:</strong> This is a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks, but it does not align with the patient\u2019s clinical picture, which includes specific ABG results and severe obesity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Central sleep apnea:</strong> Like obstructive sleep apnea, central sleep apnea occurs during sleep and involves periods of non-breathing. It does not match the daytime ABG findings of this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Obesity hypoventilation syndrome is diagnosed based on a BMI of 30 or more, daytime hypercapnia (PaCO2 &gt; 45 mm Hg), and the absence of other causes for hypercapnia.</span></p>",
    "correct_choice_id": 189669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50945,
    "choices": [
      {
        "id": 203321,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Furosemide</span></span></p>"
      },
      {
        "id": 203322,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></p>"
      },
      {
        "id": 203323,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin&nbsp; </span></span></p>"
      },
      {
        "id": 203324,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?</span></span></span></span></p>",
    "unique_key": "Q3027186",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965081,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Captopril </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril, an ACE inhibitor, has been shown to improve survival and delay the progression of heart failure. ACE inhibitors like Captopril work by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced workload on the heart. This class of drugs is considered a cornerstone in the management of heart failure with reduced ejection fraction (HF-REF). The benefits of ACE inhibitors in heart failure are well-documented, including the 1992 study on Enalapril, which demonstrated its effectiveness as a gold standard treatment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Furosemide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A loop diuretic, Furosemide is effective in reducing symptoms of congestion and decreasing heart failure hospitalization rates but does not improve survival or delay disease progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carvedilol:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;While Carvedilol, a non-selective beta-blocker, has mortality benefits and improves survival in heart failure patients, it is not preferred over ACE inhibitors as the first choice for delaying heart failure progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Digoxin:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This medication can reduce symptoms and heart failure hospitalizations to some extent, particularly in advanced heart failure, but it does not delay disease progression or improve survival, as evidenced by trials like the DIG trial.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitors, such as Captopril, are essential in delaying the progression of heart failure and improving survival.</span></span></span></span></p>",
    "correct_choice_id": 203324,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16162,
    "choices": [
      {
        "id": 64608,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative skin tuberculin test and negative chest X-ray</span></span></p>"
      },
      {
        "id": 64609,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive skin tuberculin test and positive chest X-ray</span></span></p>"
      },
      {
        "id": 64610,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive skin tuberculin test and negative chest X-ray</span></span></p>"
      },
      {
        "id": 64611,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative skin tuberculin test and positive chest X-ray</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">65-year-old male presented with unexplained fever and prolonged respiratory distress despite appropriate treatment. A diagnosis of cryptic TB was made. Which of the following is the correct statement related to this condition? (FMGE JAN 2023)</span></span></span></p>",
    "unique_key": "Q7279005",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965099,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Negative skin tuberculin test and negative chest X-ray</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryptic TB is a form of disseminated </span><span style=\"font-size:12.0pt\">miliary </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tuberculosis commonly seen in the elderly population. The term &quot;cryptic&quot; means hidden, indicating that the disease does not present with obvious clinical signs typically associated with TB. This includes a negative skin tuberculin test and no visible evidence of TB on a chest X-ray.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microbiological confirmation of TB in these patients is challenging and often not possible with standard imaging techniques. Modern guidelines suggest using advanced imaging modalities like PET CT scans to detect enlarged lymph nodes in thoracic or abdominal areas, which can be sampled for confirmation. However, even with these methods, microbiological diagnosis is still difficult</span><span style=\"font-size:12.0pt\"> (DD &ndash; Malignancy). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In such cases, empirical anti-tubercular treatment is started, and diagnosis is confirmed based on the patient&#39;s response to therapy and resolution of symptoms and lymph node enlargement over time.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Positive skin tuberculin test and positive chest X-ray</strong>: Incorrect. Cryptic TB does not typically present with a positive skin tuberculin test or obvious chest X-ray findings. The hidden nature of this form of TB means both tests are likely to be negative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Positive skin tuberculin test and negative chest X-ray</strong>: Incorrect. As mentioned, cryptic TB results in a negative skin tuberculin test, not a positive one, because the disease does not produce a strong immune response detectable by this test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Negative skin tuberculin test and positive chest X-ray</strong>: Incorrect. Cryptic TB is characterized by a lack of clear imaging evidence of TB, making a positive chest X-ray an unlikely finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryptic TB is a form of disseminated tuberculosis common in the elderly, characterized by a negative skin tuberculin test and no obvious imaging evidence of TB. Diagnosis is often confirmed through empirical treatment and advanced imaging techniques.</span></span></span></p>",
    "correct_choice_id": 64608,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20249,
    "choices": [
      {
        "id": 80957,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroid receptor antibody</span></p>"
      },
      {
        "id": 80958,
        "text": "<p><span style=\"font-size:12.0pt;\">Radioactive Iodine Uptake</span></p>"
      },
      {
        "id": 80959,
        "text": "<p><span style=\"font-size:12.0pt;\">Ultrasensitive thyrotropin</span></p>"
      },
      {
        "id": 80960,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-thyroid peroxidase antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of a sweaty palm. His appearance is as shown in the picture. What is the next step in evaluation? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-143515.jpg\" alt=\"\" width=\"300\" height=\"154\"></span></p>",
    "unique_key": "Q8785282",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965096,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ultrasensitive thyrotropin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and the clinical image strongly suggest Graves' Orbitopathy (also known as Graves' Ophthalmopathy), characterized by proptosis, eyelid edema, and eye congestion. The most common cause of both unilateral and bilateral exophthalmos is Graves' disease, an autoimmune disorder leading to hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next step in evaluating a patient suspected of having hyperthyroidism is to perform a thyroid function test (TFT), with the most important initial test being the measurement of Thyroid Stimulating Hormone (TSH). The ultrasensitive thyrotropin test, which measures TSH levels, is crucial because it helps in determining the presence of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Graves' disease, TSH levels are typically very low or undetectable, while <strong>free T4</strong> and Total T3 levels are elevated (primary hyperthyroidism).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IOC \u2013 MRI of the orbit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TOC \u2013 mild \u2013 moderate disease \u2013 conservative management</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mod.-severe disease \u2013 first line TOC \u2013 CS (Dexamethasone); </span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">Teprotumumab (IGF1 receptor inhibitor Mab)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thyroid receptor antibody:</strong> This test is specific <strong>for confirming</strong> Graves' disease, but it is not the first step. It is used after initial thyroid function tests suggest hyperthyroidism to confirm the diagnosis. The antibodies known as TRAb (TSH receptor antibody/ Thyroid receptor Ab).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 forms of TRAb \u2013 TSI (Thyroid Stimulating Immunoglobulin) and</span></p><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp; TBII (Thyroid binding Inhibitory Immunoglobulin)</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radioactive Iodine Uptake:</strong> This test helps to differentiate between various causes of hyperthyroidism, such as Graves' disease and toxic multinodular goiter. It is not the first step but follows initial thyroid function tests if hyperthyroidism is confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti thyroid peroxidase antibody:</strong> This antibody is not specific for Graves' disease. It is more commonly associated with Hashimoto's thyroiditis and other autoimmune thyroid disorders, making it less relevant for initial evaluation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first and most crucial test in the evaluation of suspected hyperthyroidism, such as in a case suggestive of Graves' disease, is the measurement of ultrasensitive thyrotropin (TSH) levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confirmatory Diagnosis \u2013 by TRAbs (Thyroid receptor antibodies)</span></p>",
    "correct_choice_id": 80959,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11348,
    "choices": [
      {
        "id": 45358,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD4+ T cell count</span></span></span></p>"
      },
      {
        "id": 45359,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load</span></span></span></p>"
      },
      {
        "id": 45360,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p24 antigen</span></span></span></p>"
      },
      {
        "id": 45361,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral serotype</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q8938833",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965121,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Viral load</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the primary method used to monitor the efficacy of antiretroviral therapy (ART) in patients with HIV. According to WHO and NACO guidelines, the monitoring of viral load is crucial for assessing the effectiveness of the treatment. Initially, viral load is <strong>monitored every six months until the regimen is stabilized</strong>. <strong>After that, it is monitored annually.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The goal of ART is to achieve an undetectable viral load, defined as <strong>less than 50 copies per mL</strong>. If the viral load is less than 50 copies, it indicates effective suppression of the virus, and the patient can continue with the same ART regimen with yearly monitoring. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">If the viral load exceeds 1000 copies, it suggests treatment failure</span></strong><span style=\"font-size:12.0pt\">, necessitating a change in the ART regimen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">For viral loads between 50 and 1000 copies, the issue is often due to poor adherence to therapy,&nbsp;</span></strong><span style=\"font-size:12.0pt\">and it is recommended to ensure adherence and frequently <strong>monitor viral load every three months</strong> until suppression is achieved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>CD4+ T cell count</strong>: Previously, CD4+ T cell count was commonly used to monitor HIV treatment. However, current guidelines prioritize viral load over CD4 count for monitoring treatment efficacy. While CD4 count is still important for assessing the immune system&#39;s health, it is not the primary marker for treatment efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>p24 antigen</strong>: The p24 antigen is a protein associated with HIV. It is used for early detection of HIV infection but is not suitable for monitoring long-term treatment efficacy. p24 levels do not provide reliable information on viral suppression or ART effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Viral serotype</strong>: Viral serotyping involves identifying different strains of HIV but does not provide information on treatment efficacy. It is more relevant in epidemiological studies and vaccine development rather than in monitoring ongoing therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the most important and recommended method for monitoring the efficacy of antiretroviral therapy in HIV patients. The goal is to achieve an undetectable viral load (&lt;50 copies/mL).</span></span></span></p>",
    "correct_choice_id": 45359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 46475,
    "choices": [
      {
        "id": 185519,
        "text": "<p><span style=\"font-size:12.0pt;\">Childhood</span></p>"
      },
      {
        "id": 185520,
        "text": "<p><span style=\"font-size:12.0pt;\">Adolescent</span></p>"
      },
      {
        "id": 185521,
        "text": "<p><span style=\"font-size:12.0pt;\">Adult</span></p>"
      },
      {
        "id": 185522,
        "text": "<p><span style=\"font-size:12.0pt;\">Elderly</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In which age group is Paget's disease of the breast not observed? (NEET PG 2017)</span></p>",
    "unique_key": "Q7334983",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965116,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. A) Childhood</strong>&nbsp;</p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Paget's disease of the breast is a rare manifestation of breast cancer characterized by unilateral nipple eczema, nipple discharge, and scaly crust. It represents the extension of ductal carcinoma in situ (DCIS) or invasive ductal carcinoma (IDC) into the nipple epidermis without basement membrane invasion. Since breast cancer is primarily a disease of older women with 75% occurring in those over 50 years of age, Paget's disease follows this pattern and is not observed in children.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Adolescent</strong>: While uncommon, breast cancer can occur in adolescents, making Paget's disease possible though rare in this age group.</p><p>&nbsp;</p><p><strong>Option C. Adult</strong>: Paget's disease is commonly observed in adults, as this is when breast cancer incidence rises significantly.</p><p>&nbsp;</p><p><strong>Option D. Elderly</strong>: The elderly population has the highest incidence of breast cancer, making Paget's disease relatively more common in this age group.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Paget's disease of the breast represents underlying ductal carcinoma extending into the nipple epidermis with characteristic clinical findings of unilateral nipple eczema and discharge. It is predominantly HER2-positive (&gt;80-90%) and HR-negative, and follows the age distribution pattern of breast cancer, being absent in childhood.</p>",
    "correct_choice_id": 185519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11200,
    "choices": [
      {
        "id": 44766,
        "text": "<p><span style=\"font-size:12.0pt;\">Lateral medullary syndrome</span></p>"
      },
      {
        "id": 44767,
        "text": "<p><span style=\"font-size:12.0pt;\">Weber syndrome</span></p>"
      },
      {
        "id": 44768,
        "text": "<p><span style=\"font-size:12.0pt;\">Medial medullary syndrome</span></p>"
      },
      {
        "id": 44769,
        "text": "<p><span style=\"font-size:12.0pt;\">Millard Gubler syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Thrombosis of posterior inferior cerebellar artery causes? (NEET PG 2018)</span></p>",
    "unique_key": "Q8085788",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965091,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Lateral Medullary syndrome.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>LATERAL MEDULLARY SYNDROME:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163123.jpg\" alt=\"\" width=\"1000\" height=\"446\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Weber is a medial midbrain syndrome caused by occlusion of PCA branches.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>Medial medullary syndrome <strong>(aka Dejerine syndrome)</strong> supplied by vertebral/spinal artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Millard-Gubler is a lateral pontine syndrome involving <strong>peripheral LMN of 7<sup>th</sup> and 6<sup>th</sup> nerve&nbsp;</strong>(NOT NUCLEUS!) supplied by AICA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164951.jpg\" alt=\"\" width=\"500\" height=\"558\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image showing arteries involved in brainstem syndromes lateral vs medial brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163156.jpg\" alt=\"\" width=\"1000\" height=\"210\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Chap 426/Neurology/stroke</strong></span></p>",
    "correct_choice_id": 44766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54257,
    "choices": [
      {
        "id": 216497,
        "text": "<p><span style=\"font-size:12.0pt;\">Synchronized DC Cardioversion</span></p>"
      },
      {
        "id": 216498,
        "text": "<p><span style=\"font-size:12.0pt;\">IV Adenosine (6mg)</span></p>"
      },
      {
        "id": 216499,
        "text": "<p><span style=\"font-size:12.0pt;\">Carotid Sinus Massage</span></p>"
      },
      {
        "id": 216500,
        "text": "<p><span style=\"font-size:12.0pt;\">IV Amiodarone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young male presented with palpitations and hence ECG was taken. ECG demonstrated narrow complex tachycardia and his BP was 70/40 mm of Hg. What is the next step in the management of this patient?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q2712669",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965106,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Synchronized DC Cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a patient presenting with palpitations, narrow complex tachycardia, and hypotension (BP 70/40 mm Hg), the patient is considered hemodynamically unstable. The appropriate management for an unstable patient with a pulse is synchronized DC cardioversion. This intervention is critical to restore normal rhythm promptly and prevent deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Synchronized cardioversion delivers a shock that is timed with the QRS complex, preventing the shock from falling on the T wave, which could induce ventricular fibrillation. This is the standard treatment for unstable supraventricular tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV Adenosine (6mg):</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Adenosine is used for the treatment of stable narrow complex tachycardia. It is not appropriate for an unstable patient due to its transient effect and the need for rapid intervention in unstable conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carotid Sinus Massage:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Carotid sinus massage is a vagal maneuver used to manage stable narrow complex tachycardia. It is not recommended for unstable patients because it may not be effective quickly enough to stabilize the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IV Amiodarone:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Amiodarone is typically used for stable wide complex tachycardia, especially monomorphic ventricular tachycardia. It is not the first-line treatment for unstable narrow complex tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hemodynamically unstable patients with narrow complex tachycardia, synchronized DC cardioversion is the immediate treatment of choice.</span></p>",
    "correct_choice_id": 216497,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16288,
    "choices": [
      {
        "id": 65112,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Frontal eye field </span></span></span></p>"
      },
      {
        "id": 65113,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cerebral surface</span></span></span></p>"
      },
      {
        "id": 65114,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brainstem</span></span></span></p>"
      },
      {
        "id": 65115,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spinal cord</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If all extraocular muscles are paralysed, where would you suspect the lesion?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(FMGE DEC 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
    "unique_key": "Q7799730",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965097,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Brainstem</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The brainstem houses the nuclei of the cranial nerves responsible for eye movements. Paralysis of all extraocular muscles suggests a lesion affecting these nuclei or their associated pathways within the brainstem.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Frontal eye field</span></strong><span style=\"font-size:12.0pt\">: Lesions here cause ipsilateral gaze deviations and saccadic eye movement disorders, not complete paralysis of extraocular muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cerebral surface</span></strong><span style=\"font-size:12.0pt\">: Cerebral lesions usually do not cause paralysis of all extraocular muscles but may affect ipsilateral voluntary eye movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Spinal cord</span></strong><span style=\"font-size:12.0pt\">: The spinal cord does not control the extraocular muscles; it is involved in motor and sensory pathways for the limbs and trunk.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paralysis of all extraocular muscles typically indicates a brainstem lesion affecting cranial nerve nuclei.</span></span></span></p>",
    "correct_choice_id": 65114,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16289,
    "choices": [
      {
        "id": 65116,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anterior wall MI</span></span></span></p>"
      },
      {
        "id": 65117,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inferior wall MI</span></span></span></p>"
      },
      {
        "id": 65118,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Posterior wall MI</span></span></span></p>"
      },
      {
        "id": 65119,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pericarditis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly obese man was brought to casualty with complaints of severe chest pain for the last two hours. He has also had profuse sweating, pain in the left arm, nausea, and one episode of vomiting. On examination, his HR is 58 and BP is 90/60 mm of Hg. ECG was done and it shows the following finding. Cardiac biomarkers showed elevated troponin levels. What is the most likely diagnosis?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(FMGE DEC 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-125138.png\" style=\"height:114px; width:300px\" /></span></span></p>",
    "unique_key": "Q5928293",
    "question_audio": null,
    "question_video": null,
    "map_id": 34965123,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Inferior wall MI</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The symptoms of severe chest pain, pain radiating to the left arm, profuse sweating, nausea, and vomiting, combined with hypotension (BP 90/60 mmHg) and bradycardia (HR - 58), strongly suggest an inferior wall myocardial infarction. Elevated troponin levels confirm myocardial injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG findings</span></strong><span style=\"font-size:12.0pt\"> &ndash; ST elevation in lead II, III &amp; aVf &ndash; inferior wall MI</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anterior wall MI</span></strong><span style=\"font-size:12.0pt\">: Typically presents with tachycardia rather than bradycardia and different ECG findings.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG</span></strong><span style=\"font-size:12.0pt\"> - ST elevation in V1 to V4 &ndash; anterior wall MI</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Posterior wall MI</span></strong><span style=\"font-size:12.0pt\">: Less common and often associated with ST depression in V1-V3 rather than the symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG - </span></strong><span style=\"font-size:12.0pt\">ST elevation in V7, V8 &amp; V9 and </span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">characteristic pattern of tall R wave, ST depression in V1-V2 and an upright T wave</span><span style=\"font-size:12.0pt\"> &ndash; Posterior wall MI</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pericarditis</span></strong><span style=\"font-size:12.0pt\">: Presents with pleuritic type of chest pain that is relieved by leaning forward and may have a pericardial friction rub on auscultation, not necessarily accompanied by the severe hemodynamic instability described here. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ECG finding &ndash; Global ST elevation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inferior wall MI is characterized by chest pain, bradycardia, hypotension, and elevated troponin levels. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MC affected right coronary artery. </span></span></span></p>",
    "correct_choice_id": 65117,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq:Pyt (Medicine-1)';
        const quizFilename = 'late-night-pyq-pyt-medicine-1-b800045c.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>